SIMILAR PATTERN OF AMINO ACIDS MAPPED TO 'SFG'
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
Interface | HETATM | RMSD | Dali Z-score |
Seq. Identity (%) |
View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1AV2_D_DVAD8_0 (GRAMICIDIN A) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 3 / 3 | VAL A 132VAL A 164TRP A 171 | SFG A 301 (-4.1A)NoneNone | 0.72A | 1av2C-3lkzA:undetectable1av2D-3lkzA:undetectable | 1av2C-3lkzA:4.301av2D-3lkzA:4.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1D4Y_A_TPVA501_1 (PROTEIN (HIV-1PROTEASE)) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 5 / 10 | LEU A 43ASP A 132GLY A 64ILE A 68VAL A 56 | NoneSFG A 501 (-3.7A)NoneNoneNone | 1.01A | 1d4yA-3axsA:undetectable | 1d4yA-3axsA:14.93 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EIZ_A_SAMA301_0 (FTSJ) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | PRO A 270GLY A 271GLY A 272ARG A 320LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-4.5A)None | 0.55A | 1eizA-2yxlA:12.0 | 1eizA-2yxlA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EIZ_A_SAMA301_0 (FTSJ) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | PRO A 94GLY A 95GLY A 96ARG A 144LEU A 193 | SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)NoneNone | 0.46A | 1eizA-3a4tA:14.2 | 1eizA-3a4tA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EIZ_A_SAMA301_0 (FTSJ) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 85GLY A 86TRP A 87ARG A 163LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)NoneSFG A 301 ( 4.1A) | 1.14A | 1eizA-3lkzA:15.4 | 1eizA-3lkzA:24.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EIZ_A_SAMA301_1 (FTSJ) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 3 / 3 | ASP A 291ASP A 318ASP A 337 | SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.58A | 1eizA-2yxlA:12.0 | 1eizA-2yxlA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EJ0_A_SAMA301_0 (FTSJ) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | PRO A 270GLY A 271GLY A 272ARG A 320LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-4.5A)None | 0.51A | 1ej0A-2yxlA:12.1 | 1ej0A-2yxlA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EJ0_A_SAMA301_0 (FTSJ) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | PRO A 94GLY A 95GLY A 96ARG A 144LEU A 193 | SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)NoneNone | 0.42A | 1ej0A-3a4tA:11.7 | 1ej0A-3a4tA:21.17 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EJ0_A_SAMA301_0 (FTSJ) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 85GLY A 86TRP A 87ARG A 163LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)NoneSFG A 301 ( 4.1A) | 1.16A | 1ej0A-3lkzA:15.3 | 1ej0A-3lkzA:24.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1EJ0_A_SAMA301_1 (FTSJ) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 3 / 3 | ASP A 291ASP A 318ASP A 337 | SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.63A | 1ej0A-2yxlA:12.1 | 1ej0A-2yxlA:21.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HMY_A_SAMA328_0 (HAEIIIMETHYLTRANSFERASE) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 8 | GLU A 248ASP A 276THR A 278PRO A 295LEU A 309 | SFG A 401 (-2.6A)SFG A 401 (-3.4A)SFG A 401 ( 4.1A)SFG A 401 ( 4.4A)None | 1.03A | 1hmyA-3tm5A:9.2 | 1hmyA-3tm5A:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1HMY_A_SAMA328_0 (HAEIIIMETHYLTRANSFERASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 5 / 8 | PHE A 488GLU A 512ASP A 539PRO A 566LEU A 588 | SFG A 700 (-4.5A)SFG A 700 (-2.1A)SFG A 700 ( 4.4A)NoneSFG A 700 (-4.9A) | 1.32A | 1hmyA-4onqA:6.8 | 1hmyA-4onqA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1JZS_A_MRCA1301_1 (ISOLEUCYL-TRNASYNTHETASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 5 / 11 | GLY A 564PRO A 566GLU A 294GLY A 332LEU A 259 | SFG A 700 ( 4.6A)NoneNoneNoneNone | 1.25A | 1jzsA-4onqA:undetectable | 1jzsA-4onqA:17.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1K4T_D_TTCD990_1 (DNA TOPOISOMERASE I) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 4 / 5 | GLU A 304ARG A 66ASP A 132THR A 159 | NoneSFG A 501 (-4.3A)SFG A 501 (-3.7A)None | 1.39A | 1k4tA-3axsA:0.1 | 1k4tA-3axsA:21.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1MX1_D_THAD4_1 (LIVERCARBOXYLESTERASE I) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | GLY A 38LEU A 105ILE A 99LEU A 100PHE A 92 | SFG A1198 (-4.3A)NoneNoneNoneNone | 0.94A | 1mx1D-2xvaA:undetectable | 1mx1D-2xvaA:16.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N49_B_RITB301_2 (PROTEASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | ARG A 37GLY A 196VAL A 214GLY A 202ILE A 234 | NoneNoneNoneSFG A 491 (-4.1A)None | 0.84A | 1n49B-3n71A:undetectable | 1n49B-3n71A:9.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N49_D_RITD401_1 (PROTEASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | ARG A 37GLY A 196VAL A 214GLY A 202ILE A 234 | NoneNoneNoneSFG A 491 (-4.1A)None | 0.85A | 1n49C-3n71A:undetectable | 1n49C-3n71A:9.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1N6C_A_SAMA402_0 (SETDOMAIN-CONTAININGPROTEIN 7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.65A | 1n6cA-3n71A:6.0 | 1n6cA-3n71A:19.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NT2_A_SAMA301_0 (FIBRILLARIN-LIKEPRE-RRNA PROCESSINGPROTEIN) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 5 / 12 | ALA A 62SER A 63SER A 86ALA A 114ASP A 132 | SFG A 501 (-3.4A)SFG A 501 ( 4.4A)SFG A 501 ( 4.7A)SFG A 501 (-3.6A)SFG A 501 (-3.7A) | 0.75A | 1nt2A-3axsA:13.7 | 1nt2A-3axsA:18.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1NT2_A_SAMA301_1 (FIBRILLARIN-LIKEPRE-RRNA PROCESSINGPROTEIN) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 3 / 3 | THR A 230GLU A 248ASP A 276 | SFG A 401 (-3.3A)SFG A 401 (-2.6A)SFG A 401 (-3.4A) | 0.68A | 1nt2A-3tm5A:14.1 | 1nt2A-3tm5A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1P6K_B_ACTB861_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 5 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.33A | 1p6kB-4onqA:undetectable | 1p6kB-4onqA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1RS6_B_ACTB861_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 5 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.33A | 1rs6B-4onqA:undetectable | 1rs6B-4onqA:21.65 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQF_A_SAMA430_0 (SUN PROTEIN) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 8 / 12 | ALA A 269GLY A 271GLY A 272LYS A 273ASP A 293ASP A 318ARG A 320PRO A 339 | SFG A5748 (-4.3A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-3.7A)SFG A5748 (-4.5A)SFG A5748 (-4.0A) | 0.72A | 1sqfA-2yxlA:40.8 | 1sqfA-2yxlA:29.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQF_A_SAMA430_0 (SUN PROTEIN) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 8 / 12 | CYH A 91ALA A 93GLY A 95GLY A 96LYS A 97ILE A 116ARG A 144PRO A 165 | SFG A 500 (-3.8A)SFG A 500 (-3.7A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)NoneSFG A 500 (-3.9A) | 0.58A | 1sqfA-3a4tA:28.8 | 1sqfA-3a4tA:24.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQF_A_SAMA430_0 (SUN PROTEIN) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 8 / 12 | CYH A 91ALA A 93GLY A 95GLY A 96LYS A 97ILE A 116ASP A 142ARG A 144 | SFG A 500 (-3.8A)SFG A 500 (-3.7A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-4.0A)None | 0.58A | 1sqfA-3a4tA:28.8 | 1sqfA-3a4tA:24.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1SQF_A_SAMA430_1 (SUN PROTEIN) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 3 / 3 | PRO A 270ASP A 291ASP A 337 | SFG A5748 (-3.6A)SFG A5748 (-2.9A)SFG A5748 (-3.6A) | 0.48A | 1sqfA-2yxlA:40.8 | 1sqfA-2yxlA:29.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UAK_A_SAMA301_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 12 / 12 | LEU A 92SER A 93PRO A 94GLN A 95GLY A 118SER A 137ILE A 138VAL A 142LEU A 143GLY A 145GLY A 146PRO A 149 | SFG A 400 (-4.6A)NoneSFG A 400 (-3.7A)SFG A 400 (-2.7A)SFG A 400 (-3.4A)SFG A 400 (-3.3A)SFG A 400 (-4.4A)SFG A 400 ( 4.1A)SFG A 400 (-4.2A)SFG A 400 (-3.2A)SFG A 400 (-3.7A)SFG A 400 (-4.4A) | 0.29A | 1uakA-5wyrA:29.7 | 1uakA-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UAK_A_SAMA301_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 6 / 12 | PRO A 94GLN A 95GLY A 118LEU A 143GLY A 146PRO A 149 | SFG A 400 (-3.7A)SFG A 400 (-2.7A)SFG A 400 (-3.4A)SFG A 400 (-4.2A)SFG A 400 (-3.7A)SFG A 400 (-4.4A) | 1.28A | 1uakA-5wyrA:29.7 | 1uakA-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1UAK_A_SAMA301_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 6 / 12 | SER A 93PRO A 94GLN A 95GLY A 118LEU A 143GLY A 145 | NoneSFG A 400 (-3.7A)SFG A 400 (-2.7A)SFG A 400 (-3.4A)SFG A 400 (-4.2A)SFG A 400 (-3.2A) | 1.22A | 1uakA-5wyrA:29.7 | 1uakA-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1W5U_D_DVAD8_0 (GRAMICIDIN D) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 3 / 3 | VAL A 132VAL A 164TRP A 171 | SFG A 301 (-4.1A)NoneNone | 0.73A | 1w5uC-3lkzA:undetectable1w5uD-3lkzA:undetectable | 1w5uC-3lkzA:4.301w5uD-3lkzA:4.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ZZU_B_ACTB861_0 (NITRIC-OXIDESYNTHASE, BRAIN) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 5 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.33A | 1zzuB-4onqA:undetectable | 1zzuB-4onqA:21.48 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2AVV_E_MK1E902_1 (POL POLYPROTEIN) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 5 / 12 | GLY A 332VAL A 467ILE A 562GLY A 563GLY A 564 | NoneNoneNoneNoneSFG A 700 ( 4.6A) | 0.76A | 2avvD-4onqA:undetectable | 2avvD-4onqA:15.38 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2B9E_A_SAMA1201_0 (NOL1/NOP2/SUN DOMAINFAMILY, MEMBER 5ISOFORM 2) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | PRO A 270GLY A 271LYS A 273ASP A 293ARG A 296ASP A 318 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-3.0A)SFG A5748 (-3.7A) | 0.70A | 2b9eA-2yxlA:31.1 | 2b9eA-2yxlA:25.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2B9E_A_SAMA1201_0 (NOL1/NOP2/SUN DOMAINFAMILY, MEMBER 5ISOFORM 2) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | CYH A 91PRO A 94GLY A 95LYS A 97ASP A 142 | SFG A 500 (-3.8A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-2.8A)SFG A 500 (-4.0A) | 0.31A | 2b9eA-3a4tA:28.7 | 2b9eA-3a4tA:28.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BR4_E_SAME301_1 (CEPHALOSPORINHYDROXYLASE CMCI) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 3 / 3 | SER A 56ASP A 146CYH A 180 | SFG A 301 (-2.6A)SFG A 301 (-3.8A)None | 0.92A | 2br4E-3lkzA:6.7 | 2br4E-3lkzA:19.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2BXF_B_DZPB2001_1 (SERUM ALBUMIN) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | ILE C 321ASN C 368LEU C 426GLU C 376ARG C 375 | NoneSFG C1002 (-4.1A)NoneNoneNone | 1.29A | 2bxfB-5hr4C:undetectable | 2bxfB-5hr4C:20.34 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2EJT_A_SAMA501_0 (N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | ASP A 89ALA A 93ILE A 116SER A 117ASP A 163 | SFG A 500 ( 4.4A)SFG A 500 (-3.7A)SFG A 500 (-3.7A)NoneSFG A 500 (-3.7A) | 0.82A | 2ejtA-3a4tA:11.4 | 2ejtA-3a4tA:23.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EJT_A_SAMA501_0 (N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 5 / 12 | ASP A 58ILE A 68ASN A 83ILE A 85ALA A 114 | SFG A 501 ( 4.6A)NoneSFG A 501 ( 4.7A)SFG A 501 (-3.7A)SFG A 501 (-3.6A) | 1.18A | 2ejtA-3axsA:44.3 | 2ejtA-3axsA:38.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2EJT_A_SAMA501_0 (N(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASE) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 11 / 12 | ASP A 58LEU A 60ALA A 62ILE A 65ARG A 66ASN A 83ILE A 85SER A 86ALA A 114ASP A 132PHE A 140 | SFG A 501 ( 4.6A)SFG A 501 (-3.7A)SFG A 501 (-3.4A)NoneSFG A 501 (-4.3A)SFG A 501 ( 4.7A)SFG A 501 (-3.7A)SFG A 501 ( 4.7A)SFG A 501 (-3.6A)SFG A 501 (-3.7A)None | 0.50A | 2ejtA-3axsA:44.3 | 2ejtA-3axsA:38.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2F8L_A_SAMA400_0 (HYPOTHETICAL PROTEINLMO1582) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | ALA A 267VAL A 292ASP A 293ASP A 337PRO A 339 | SFG A5748 (-3.4A)SFG A5748 ( 3.9A)NoneSFG A5748 (-3.6A)SFG A5748 (-4.0A) | 0.86A | 2f8lA-2yxlA:12.7 | 2f8lA-2yxlA:23.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2GLU_A_SAMA301_0 (YCGJ) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.70A | 2gluA-4ox9Y:12.5 | 2gluA-4ox9Y:24.23 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_A_SAMA801_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 10 | GLY A 18ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.60A | 2h21A-3n71A:9.2 | 2h21A-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_A_SAMA801_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | GLY A 20HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.16A | 2h21A-3n71A:9.2 | 2h21A-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_A_SAMA801_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | GLY A 20LEU A 203HIS A 206TYR A 252PHE A 272 | NoneNoneNoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) | 1.34A | 2h21A-3n71A:9.2 | 2h21A-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_B_SAMB802_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.28A | 2h21B-3n71A:11.9 | 2h21B-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_B_SAMB802_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.52A | 2h21B-3n71A:11.9 | 2h21B-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_B_SAMB802_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 20HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.19A | 2h21B-3n71A:11.9 | 2h21B-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_B_SAMB802_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 20LEU A 203HIS A 206TYR A 252PHE A 272 | NoneNoneNoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) | 1.36A | 2h21B-3n71A:11.9 | 2h21B-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.33A | 2h21C-3n71A:8.6 | 2h21C-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.54A | 2h21C-3n71A:8.6 | 2h21C-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 20HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.16A | 2h21C-3n71A:8.6 | 2h21C-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 20LEU A 203HIS A 206TYR A 252PHE A 272 | NoneNoneNoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) | 1.32A | 2h21C-3n71A:8.6 | 2h21C-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2H21_C_SAMC803_0 (RIBULOSE-1,5BISPHOSPHATECARBOXYLASE/OXYGENASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | LEU A 203ASN A 205HIS A 206TYR A 252PHE A 272 | NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) | 1.47A | 2h21C-3n71A:8.6 | 2h21C-3n71A:23.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HMY_B_SAMB328_0 (PROTEIN(CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI)) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 6 / 12 | PHE A 488GLY A 490GLY A 493ASP A 539PRO A 566LEU A 588 | SFG A 700 (-4.5A)SFG A 700 (-3.5A)SFG A 700 (-3.6A)SFG A 700 ( 4.4A)NoneSFG A 700 (-4.9A) | 1.25A | 2hmyB-4onqA:6.6 | 2hmyB-4onqA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2HMY_B_SAMB328_0 (PROTEIN(CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI)) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 6 / 12 | PHE A 488GLY A 490GLY A 494ASP A 539PRO A 566LEU A 588 | SFG A 700 (-4.5A)SFG A 700 (-3.5A)NoneSFG A 700 ( 4.4A)NoneSFG A 700 (-4.9A) | 1.43A | 2hmyB-4onqA:6.6 | 2hmyB-4onqA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NXE_B_SAMB303_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | ASP Y 30LEU Y 31GLY Y 32GLY Y 34LEU Y 110 | SFG Y 301 ( 4.7A)NoneSFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.0A) | 0.72A | 2nxeB-4ox9Y:3.5 | 2nxeB-4ox9Y:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYU_A_SAMA201_0 (PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 81GLY A 85TRP A 87VAL A 132LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 ( 4.1A) | 0.32A | 2nyuA-3lkzA:14.5 | 2nyuA-3lkzA:19.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYU_A_SAMA201_1 (PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 4 / 4 | PRO A 270ASP A 291ASP A 318ASP A 265 | SFG A5748 (-3.6A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 ( 4.4A) | 0.96A | 2nyuA-2yxlA:11.7 | 2nyuA-2yxlA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYU_A_SAMA201_1 (PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 4 / 4 | PRO A 270ASP A 291ASP A 318ASP A 337 | SFG A5748 (-3.6A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.50A | 2nyuA-2yxlA:11.7 | 2nyuA-2yxlA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYU_B_SAMB201_0 (PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 81GLY A 85TRP A 87VAL A 132LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 ( 4.1A) | 0.36A | 2nyuB-3lkzA:14.6 | 2nyuB-3lkzA:19.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYU_B_SAMB201_1 (PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 4 / 5 | PRO A 270ASP A 291ASP A 318ASP A 265 | SFG A5748 (-3.6A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 ( 4.4A) | 1.02A | 2nyuB-2yxlA:11.9 | 2nyuB-2yxlA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2NYU_B_SAMB201_1 (PUTATIVE RIBOSOMALRNAMETHYLTRANSFERASE 2) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 4 / 5 | PRO A 270ASP A 291ASP A 318ASP A 337 | SFG A5748 (-3.6A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.46A | 2nyuB-2yxlA:11.9 | 2nyuB-2yxlA:19.10 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2O4P_A_TPVA300_1 (PROTEASE) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 5 / 11 | LEU A 43ASP A 132GLY A 64ILE A 68VAL A 56 | NoneSFG A 501 (-3.7A)NoneNoneNone | 1.06A | 2o4pA-3axsA:undetectable | 2o4pA-3axsA:16.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OKC_A_SAMA500_0 (TYPE I RESTRICTIONENZYME STYSJI MPROTEIN) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | ILE C 321ALA C 363GLY C 365ASN C 481PRO C 483 | NoneSFG C1002 (-3.9A)SFG C1002 (-3.4A)SFG C1002 (-3.8A)SFG C1002 (-4.1A) | 0.32A | 2okcA-5hr4C:18.2 | 2okcA-5hr4C:19.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2OKC_B_SAMB500_0 (TYPE I RESTRICTIONENZYME STYSJI MPROTEIN) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | ILE C 321ALA C 363GLY C 365ASN C 481PRO C 483 | NoneSFG C1002 (-3.9A)SFG C1002 (-3.4A)SFG C1002 (-3.8A)SFG C1002 (-4.1A) | 0.34A | 2okcB-5hr4C:18.4 | 2okcB-5hr4C:19.47 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_A_SAMA300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 146 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-3.8A) | 0.64A | 2oxtA-3lkzA:39.7 | 2oxtA-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_A_SAMA300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.39A | 2oxtA-3lkzA:39.7 | 2oxtA-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_B_SAMB300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58GLY A 81GLY A 83GLY A 85TRP A 87THR A 104GLU A 111LYS A 182 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 ( 4.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 ( 4.1A) | 0.66A | 2oxtB-3lkzA:39.7 | 2oxtB-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_B_SAMB300_1 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 4 / 5 | SER A 56GLY A 86ASP A 131ASP A 146 | SFG A 301 (-2.6A)SFG A 301 (-3.4A)SFG A 301 (-3.1A)SFG A 301 (-3.8A) | 0.50A | 2oxtB-3lkzA:39.7 | 2oxtB-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_B_SAMB300_1 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 4 / 5 | SER A 56GLY A 86HIS A 110ASP A 146 | SFG A 301 (-2.6A)SFG A 301 (-3.4A)SFG A 301 (-3.9A)SFG A 301 (-3.8A) | 0.22A | 2oxtB-3lkzA:39.7 | 2oxtB-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_C_SAMC300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 146LYS A 182 | SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-3.8A)SFG A 301 ( 4.1A) | 0.76A | 2oxtC-3lkzA:39.5 | 2oxtC-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58ASP A 79GLY A 81GLY A 83GLY A 86THR A 104HIS A 110ASP A 146 | SFG A 301 (-2.9A)SFG A 301 ( 4.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.8A) | 0.46A | 2oxtD-3lkzA:39.7 | 2oxtD-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 58ASP A 79GLY A 83GLY A 86THR A 104GLU A 111ASP A 146 | SFG A 301 (-2.9A)SFG A 301 ( 4.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-3.8A) | 0.92A | 2oxtD-3lkzA:39.7 | 2oxtD-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2OXT_D_SAMD300_0 (NUCLEOSIDE-2'-O-METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.44A | 2oxtD-3lkzA:39.7 | 2oxtD-3lkzA:50.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PXC_A_SAMA500_0 (GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)]) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.39A | 2pxcA-3lkzA:43.0 | 2pxcA-3lkzA:80.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2PXC_A_SAMA500_0 (GENOME POLYPROTEIN[CONTAINS: CAPSIDPROTEIN C (COREPROTEIN) ENVELOPE PROTEIN M(MATRIX PROTEIN) MAJOR ENVELOPEPROTEIN E NON-STRUCTURALPROTEIN 1 (NS1) NON-STRUCTURALPROTEIN 2A (NS2A) FLAVIVIRIN PROTEASENS2B REGULATORYSUBUNIT FLAVIVIRIN PROTEASENS3 CATALYTICSUBUNIT NON-STRUCTURALPROTEIN 4A (NS4A) NON-STRUCTURALPROTEIN 4B (NS4B) RNA-DIRECTED RNAPOLYMERASE (EC2.7.7.48) (NS5)]) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.30A | 2pxcA-3lkzA:43.0 | 2pxcA-3lkzA:80.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QM9_A_TDZA201_1 (FATTY ACID-BINDINGPROTEIN, ADIPOCYTE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | ALA A 319THR A 274ALA A 268ASP A 291ARG A 296 | SFG A5748 (-3.4A)NoneNoneSFG A5748 (-2.9A)SFG A5748 (-3.0A) | 1.40A | 2qm9A-2yxlA:undetectable | 2qm9A-2yxlA:17.13 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QMM_A_SAMA301_0 (UPF0217 PROTEINAF_1056) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 9 | LEU A 92GLY A 118GLY A 122SER A 137LEU A 143 | SFG A 400 (-4.6A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 (-3.3A)SFG A 400 (-4.2A) | 0.79A | 2qmmA-5wyrA:7.3 | 2qmmA-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2QMM_B_SAMB301_0 (UPF0217 PROTEINAF_1056) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 11 | LEU A 92GLY A 118GLY A 122SER A 137LEU A 143 | SFG A 400 (-4.6A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 (-3.3A)SFG A 400 (-4.2A) | 0.85A | 2qmmA-5wyrA:7.32qmmB-5wyrA:7.2 | 2qmmA-5wyrA:undetectable2qmmB-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R3A_A_SAMA304_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.02A | 2r3aA-3n71A:5.4 | 2r3aA-3n71A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2R3A_A_SAMA304_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV39H2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252CYH A 274CYH A 276LEU A 266 | NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A)None | 1.24A | 2r3aA-3n71A:5.4 | 2r3aA-3n71A:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UYQ_A_SAMA1311_0 (HYPOTHETICAL PROTEINML2640) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 4 / 7 | GLY A 40ASP A 59ASP A 86LEU A 87 | SFG A1198 (-3.2A)SFG A1198 (-2.8A)SFG A1198 (-3.9A)SFG A1198 (-3.8A) | 0.49A | 2uyqA-2xvaA:13.4 | 2uyqA-2xvaA:22.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2UYQ_A_SAMA1311_0 (HYPOTHETICAL PROTEINML2640) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 4 / 7 | ALA A 267ASP A 291ASP A 318ARG A 320 | SFG A5748 (-3.4A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-4.5A) | 0.66A | 2uyqA-2yxlA:9.4 | 2uyqA-2yxlA:20.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VDV_E_SAME1287_0 (TRNA(GUANINE-N(7)-)-METHYLTRANSFERASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 6 / 12 | GLY C 365GLU C 413ILE C 414ASN C 460ALA C 461THR C 316 | SFG C1002 (-3.4A)SFG C1002 (-2.8A)SFG C1002 (-3.9A)SFG C1002 (-3.2A)SFG C1002 (-3.8A)SFG C1002 (-4.0A) | 0.87A | 2vdvE-5hr4C:7.1 | 2vdvE-5hr4C:14.18 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2VDV_F_SAMF1287_0 (TRNA(GUANINE-N(7)-)-METHYLTRANSFERASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 6 / 11 | GLY C 365GLU C 413ILE C 414ASN C 460ALA C 461THR C 316 | SFG C1002 (-3.4A)SFG C1002 (-2.8A)SFG C1002 (-3.9A)SFG C1002 (-3.2A)SFG C1002 (-3.8A)SFG C1002 (-4.0A) | 0.87A | 2vdvF-5hr4C:7.1 | 2vdvF-5hr4C:14.18 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WA2_A_SAMA1248_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58GLY A 81GLY A 83TRP A 87THR A 104ASP A 131VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.59A | 2wa2A-3lkzA:33.2 | 2wa2A-3lkzA:43.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WA2_A_SAMA1248_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 58GLY A 83THR A 104GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.96A | 2wa2A-3lkzA:33.2 | 2wa2A-3lkzA:43.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WA2_B_SAMB1267_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | SER A 56GLY A 58GLY A 81GLY A 83TRP A 87THR A 104VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.38A | 2wa2B-3lkzA:41.0 | 2wa2B-3lkzA:43.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2WA2_B_SAMB1267_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | SER A 56GLY A 58GLY A 83THR A 104GLU A 111VAL A 132 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.93A | 2wa2B-3lkzA:41.0 | 2wa2B-3lkzA:43.69 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZBP_A_SAMA300_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | LEU A 37GLY A 38GLY A 40LEU A 87LEU A 90 | NoneSFG A1198 (-4.3A)SFG A1198 (-3.2A)SFG A1198 (-3.8A)None | 0.81A | 2zbpA-2xvaA:14.2 | 2zbpA-2xvaA:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZIF_A_SAMA298_0 (PUTATIVEMODIFICATIONMETHYLASE) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | ALA A 277PRO A 295GLY A 227THR A 230GLU A 248 | SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 ( 3.7A)SFG A 401 (-3.3A)SFG A 401 (-2.6A) | 0.56A | 2zifA-3tm5A:3.2 | 2zifA-3tm5A:22.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2ZW9_B_SAMB801_0 (LEUCINE CARBOXYLMETHYLTRANSFERASE 2) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | GLY A 38GLY A 40ASP A 86LEU A 87ASN A 88 | SFG A1198 (-4.3A)SFG A1198 (-3.2A)SFG A1198 (-3.9A)SFG A1198 (-3.8A)SFG A1198 (-4.0A) | 0.51A | 2zw9B-2xvaA:12.3 | 2zw9B-2xvaA:14.12 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ADS_A_IMNA2_1 (PEROXISOMEPROLIFERATOR-ACTIVATED RECEPTOR GAMMA) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | PHE Y 135LEU Y 110LEU Y 128LEU Y 172TYR Y 168 | NoneSFG Y 301 (-4.0A)NoneNoneNone | 1.22A | 3adsA-4ox9Y:undetectable | 3adsA-4ox9Y:21.25 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3AV6_A_SAMA1_0 (DNA(CYTOSINE-5)-METHYLTRANSFERASE 1) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 6 / 12 | PHE A 488GLY A 490GLY A 493PRO A 566LEU A 588ASN A 460 | SFG A 700 (-4.5A)SFG A 700 (-3.5A)SFG A 700 (-3.6A)NoneSFG A 700 (-4.9A)None | 1.45A | 3av6A-4onqA:undetectable | 3av6A-4onqA:14.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AXT_A_SAMA397_0 (PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 12 / 12 | ARG A 36LEU A 60ALA A 62ILE A 65ARG A 66ASP A 84ILE A 85SER A 86GLU A 113ALA A 114ASP A 132PHE A 134 | SFG A 501 (-4.2A)SFG A 501 (-3.7A)SFG A 501 (-3.4A)NoneSFG A 501 (-4.3A)SFG A 501 (-2.8A)SFG A 501 (-3.7A)SFG A 501 ( 4.7A)SFG A 501 (-4.0A)SFG A 501 (-3.6A)SFG A 501 (-3.7A)SFG A 501 (-3.3A) | 0.20A | 3axtA-3axsA:66.8 | 3axtA-3axsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AXT_A_SAMA397_0 (PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 5 / 12 | ILE A 68ASP A 84ILE A 85GLU A 113ALA A 114 | NoneSFG A 501 (-2.8A)SFG A 501 (-3.7A)SFG A 501 (-4.0A)SFG A 501 (-3.6A) | 1.04A | 3axtA-3axsA:66.8 | 3axtA-3axsA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3AXZ_A_ADNA401_1 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 12 / 12 | TYR A 91LEU A 92SER A 93PRO A 94GLY A 118GLY A 122SER A 137ILE A 138LEU A 143GLY A 145GLY A 146PRO A 149 | SFG A 400 (-4.6A)SFG A 400 (-4.6A)NoneSFG A 400 (-3.7A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 (-3.3A)SFG A 400 (-4.4A)SFG A 400 (-4.2A)SFG A 400 (-3.2A)SFG A 400 (-3.7A)SFG A 400 (-4.4A) | 0.35A | 3axzA-5wyrA:24.7 | 3axzA-5wyrA:31.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CJT_C_SAMC302_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | ASP A 36LEU A 37GLY A 38ASP A 59LEU A 108 | SFG A1198 ( 4.7A)NoneSFG A1198 (-4.3A)SFG A1198 (-2.8A)SFG A1198 (-4.8A) | 0.92A | 3cjtC-2xvaA:14.7 | 3cjtC-2xvaA:21.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CJT_C_SAMC302_0 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | ASP Y 30LEU Y 31GLY Y 32ASP Y 55LEU Y 110 | SFG Y 301 ( 4.7A)NoneSFG Y 301 (-3.9A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A) | 0.82A | 3cjtC-4ox9Y:10.7 | 3cjtC-4ox9Y:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3CKK_A_SAMA301_0 (TRNA(GUANINE-N(7)-)-METHYLTRANSFERASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 6 / 12 | GLY C 365GLU C 413ILE C 414ASN C 460ALA C 461THR C 316 | SFG C1002 (-3.4A)SFG C1002 (-2.8A)SFG C1002 (-3.9A)SFG C1002 (-3.2A)SFG C1002 (-3.8A)SFG C1002 (-4.0A) | 0.92A | 3ckkA-5hr4C:7.2 | 3ckkA-5hr4C:13.49 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DOU_A_SAMA1_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 81GLY A 85GLY A 86TRP A 87LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.1A) | 0.40A | 3douA-3lkzA:14.3 | 3douA-3lkzA:20.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3DOU_A_SAMA1_1 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 3 / 3 | ASP A 291ASP A 318ASP A 337 | SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.49A | 3douA-2yxlA:10.4 | 3douA-2yxlA:20.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEO_A_SAMA328_0 (MODIFICATIONMETHYLASE HHAI) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | GLY A 272ASP A 293ASP A 318PRO A 339LEU A 371 | SFG A5748 (-3.7A)NoneSFG A5748 (-3.7A)SFG A5748 (-4.0A)None | 0.93A | 3eeoA-2yxlA:9.0 | 3eeoA-2yxlA:21.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EEO_A_SAMA328_0 (MODIFICATIONMETHYLASE HHAI) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 5 / 12 | PHE A 488GLY A 493ASP A 539LEU A 588ASN A 460 | SFG A 700 (-4.5A)SFG A 700 (-3.6A)SFG A 700 ( 4.4A)SFG A 700 (-4.9A)None | 0.90A | 3eeoA-4onqA:7.1 | 3eeoA-4onqA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3ELU_A_SAMA4633_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132PHE A 133ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.52A | 3eluA-3lkzA:39.8 | 3eluA-3lkzA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELW_A_SAMA4633_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132PHE A 133ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.45A | 3elwA-3lkzA:40.7 | 3elwA-3lkzA:52.87 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3ELW_A_SAMA4633_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.34A | 3elwA-3lkzA:40.7 | 3elwA-3lkzA:52.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EMB_A_SAMA4633_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.59A | 3embA-3lkzA:40.6 | 3embA-3lkzA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3EMB_A_SAMA4633_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.39A | 3embA-3lkzA:40.6 | 3embA-3lkzA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUU_A_ADNA0_1 (DIMETHYLADENOSINETRANSFERASE) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | GLY A 227GLU A 248LYS A 249ALA A 277PRO A 295 | SFG A 401 ( 3.7A)SFG A 401 (-2.6A)SFG A 401 (-4.9A)SFG A 401 (-3.1A)SFG A 401 ( 4.4A) | 0.96A | 3fuuA-3tm5A:14.5 | 3fuuA-3tm5A:23.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3FUU_A_ADNA0_1 (DIMETHYLADENOSINETRANSFERASE) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | GLY A 227GLU A 248LYS A 249ASP A 276ALA A 277 | SFG A 401 ( 3.7A)SFG A 401 (-2.6A)SFG A 401 (-4.9A)SFG A 401 (-3.4A)SFG A 401 (-3.1A) | 0.87A | 3fuuA-3tm5A:14.5 | 3fuuA-3tm5A:23.97 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G88_A_SAMA303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 11 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.63A | 3g88A-4ox9Y:13.2 | 3g88A-4ox9Y:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G88_B_SAMB303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 11 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.62A | 3g88B-4ox9Y:12.9 | 3g88B-4ox9Y:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G89_A_SAMA303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.70A | 3g89A-4ox9Y:13.2 | 3g89A-4ox9Y:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G89_B_SAMB303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 11 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.71A | 3g89B-4ox9Y:13.1 | 3g89B-4ox9Y:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G8B_A_SAMA303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.74A | 3g8bA-4ox9Y:13.1 | 3g8bA-4ox9Y:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3G8B_B_SAMB303_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE G) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | GLY Y 32GLY Y 34ASP Y 55ALA Y 87GLU Y 88 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A) | 0.73A | 3g8bB-4ox9Y:11.6 | 3g8bB-4ox9Y:21.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GCZ_A_SAMA4633_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.32A | 3gczA-3lkzA:40.7 | 3gczA-3lkzA:53.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3GCZ_A_SAMA4633_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.51A | 3gczA-3lkzA:40.7 | 3gczA-3lkzA:53.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GRV_A_ADNA300_1 (DIMETHYLADENOSINETRANSFERASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 11 | GLU C 413ILE C 414ALA C 461ASN C 481PRO C 483 | SFG C1002 (-2.8A)SFG C1002 (-3.9A)SFG C1002 (-3.8A)SFG C1002 (-3.8A)SFG C1002 (-4.1A) | 0.69A | 3grvA-5hr4C:13.1 | 3grvA-5hr4C:16.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GRY_A_SAMA300_0 (DIMETHYLADENOSINETRANSFERASE) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 12 | LEU A 202GLU A 248ASP A 276ALA A 277ASN A 293PRO A 295 | SFG A 401 (-4.5A)SFG A 401 (-2.6A)SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 (-4.4A)SFG A 401 ( 4.4A) | 1.21A | 3gryA-3tm5A:15.4 | 3gryA-3tm5A:22.76 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3GRY_A_SAMA300_0 (DIMETHYLADENOSINETRANSFERASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | GLU C 413ILE C 414ALA C 461ASN C 481PRO C 483 | SFG C1002 (-2.8A)SFG C1002 (-3.9A)SFG C1002 (-3.8A)SFG C1002 (-3.8A)SFG C1002 (-4.1A) | 0.71A | 3gryA-5hr4C:13.0 | 3gryA-5hr4C:16.19 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KK6_A_CELA701_2 (PROSTAGLANDIN G/HSYNTHASE 1) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 4 / 6 | VAL A 22LEU A 87ILE A 65LEU A 100 | NoneSFG A1198 (-3.8A)NoneNone | 0.93A | 3kk6A-2xvaA:undetectable | 3kk6A-2xvaA:14.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3KU1_C_SAMC226_0 (SAM-DEPENDENTMETHYLTRANSFERASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | PRO A 314GLY A 272GLY A 308MET A 307ILE A 242 | NoneSFG A5748 (-3.7A)NoneNoneNone | 0.93A | 3ku1C-2yxlA:10.9 | 3ku1C-2yxlA:19.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L8L_B_DVAB8_0 (GRAMICIDIN D) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 3 / 3 | VAL A 132VAL A 164TRP A 171 | SFG A 301 (-4.1A)NoneNone | 0.72A | 3l8lA-3lkzA:undetectable3l8lB-3lkzA:undetectable | 3l8lA-3lkzA:4.303l8lB-3lkzA:5.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3L8L_D_DVAD8_0 (GRAMICIDIN D) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 3 / 3 | VAL A 132VAL A 164TRP A 171 | SFG A 301 (-4.1A)NoneNone | 0.77A | 3l8lC-3lkzA:undetectable3l8lD-3lkzA:undetectable | 3l8lC-3lkzA:4.303l8lD-3lkzA:5.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 8 / 12 | ALA A 267GLY A 271GLY A 272LYS A 273VAL A 292ASP A 293ARG A 296ASP A 337 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 ( 3.9A)NoneSFG A5748 (-3.0A)SFG A5748 (-3.6A) | 0.90A | 3m6vA-2yxlA:37.6 | 3m6vA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | ALA A 267GLY A 272LYS A 273ASP A 293ARG A 296ASP A 337 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-3.0A)SFG A5748 (-3.6A) | 1.10A | 3m6vA-2yxlA:37.6 | 3m6vA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | ALA A 267GLY A 272LYS A 273ASP A 293ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.92A | 3m6vA-2yxlA:37.6 | 3m6vA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 10 / 12 | ALA A 267PRO A 270GLY A 271GLY A 272LYS A 273VAL A 292ASP A 293ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 ( 3.9A)NoneSFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.78A | 3m6vA-2yxlA:37.6 | 3m6vA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | PRO A 270GLY A 271VAL A 292ASP A 293PRO A 339LEU A 367 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 ( 3.9A)NoneSFG A5748 (-4.0A)None | 1.50A | 3m6vA-2yxlA:37.6 | 3m6vA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | LYS A 97ARG A 120ASP A 163PRO A 165LEU A 193 | SFG A 500 (-2.8A)SFG A 500 (-4.4A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 1.02A | 3m6vA-3a4tA:31.3 | 3m6vA-3a4tA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_A_SAMA465_0 (RRNA METHYLASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 7 / 12 | PRO A 94GLY A 95GLY A 96LYS A 97ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 0.47A | 3m6vA-3a4tA:31.3 | 3m6vA-3a4tA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 8 / 12 | ALA A 267GLY A 271GLY A 272LYS A 273VAL A 292ASP A 293ARG A 296ASP A 337 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 ( 3.9A)NoneSFG A5748 (-3.0A)SFG A5748 (-3.6A) | 0.92A | 3m6vB-2yxlA:37.5 | 3m6vB-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | ALA A 267GLY A 272LYS A 273ASP A 293ARG A 296ASP A 337 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-3.0A)SFG A5748 (-3.6A) | 1.09A | 3m6vB-2yxlA:37.5 | 3m6vB-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | ALA A 267GLY A 272LYS A 273ASP A 293ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.92A | 3m6vB-2yxlA:37.5 | 3m6vB-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 10 / 12 | ALA A 267PRO A 270GLY A 271GLY A 272LYS A 273VAL A 292ASP A 293ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 ( 3.9A)NoneSFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.84A | 3m6vB-2yxlA:37.5 | 3m6vB-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | PRO A 270GLY A 271VAL A 292ASP A 293PRO A 339LEU A 367 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 ( 3.9A)NoneSFG A5748 (-4.0A)None | 1.47A | 3m6vB-2yxlA:37.5 | 3m6vB-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | GLY A 96LYS A 97ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 1.05A | 3m6vB-3a4tA:31.1 | 3m6vB-3a4tA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | LYS A 97ARG A 120ASP A 163PRO A 165LEU A 193 | SFG A 500 (-2.8A)SFG A 500 (-4.4A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 1.02A | 3m6vB-3a4tA:31.1 | 3m6vB-3a4tA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6V_B_SAMB465_0 (RRNA METHYLASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 7 / 12 | PRO A 94GLY A 95GLY A 96LYS A 97ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 0.47A | 3m6vB-3a4tA:31.1 | 3m6vB-3a4tA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6W_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | ALA A 267GLY A 272LYS A 273ASP A 293PRO A 339LEU A 371 | SFG A5748 (-3.4A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)NoneSFG A5748 (-4.0A)None | 0.92A | 3m6wA-2yxlA:37.6 | 3m6wA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6W_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 9 / 12 | ALA A 267PRO A 270GLY A 271GLY A 272LYS A 273VAL A 292ASP A 293PRO A 339LEU A 371 | SFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 ( 3.9A)NoneSFG A5748 (-4.0A)None | 0.83A | 3m6wA-2yxlA:37.6 | 3m6wA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6W_A_SAMA465_0 (RRNA METHYLASE) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | GLY A 271GLY A 272LYS A 273VAL A 292ASP A 293ARG A 296 | SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 ( 3.9A)NoneSFG A5748 (-3.0A) | 0.85A | 3m6wA-2yxlA:37.6 | 3m6wA-2yxlA:24.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3M6W_A_SAMA465_0 (RRNA METHYLASE) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 6 / 12 | PRO A 94GLY A 95GLY A 96LYS A 97PRO A 165LEU A 193 | SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-3.9A)None | 0.46A | 3m6wA-3a4tA:31.2 | 3m6wA-3a4tA:22.59 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3MBG_C_ACTC800_0 (FAD-LINKEDSULFHYDRYL OXIDASEALR) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 3 / 3 | ASP A 130ARG A 36ALA A 39 | NoneSFG A 501 (-4.2A)None | 0.67A | 3mbgC-3axsA:undetectable | 3mbgC-3axsA:12.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MEK_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.19A | 3mekA-3n71A:38.4 | 3mekA-3n71A:30.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MEK_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.45A | 3mekA-3n71A:38.4 | 3mekA-3n71A:30.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MEK_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.06A | 3mekA-3n71A:38.4 | 3mekA-3n71A:30.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_A_SAMA220_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | GLY Y 32GLY Y 34PRO Y 56ALA Y 85LEU Y 104 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A)NoneSFG Y 301 (-4.6A) | 1.26A | 3mteA-4ox9Y:34.9 | 3mteA-4ox9Y:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_A_SAMA220_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 9 / 12 | GLY Y 32GLY Y 34PRO Y 56VAL Y 57ALA Y 86ALA Y 87LEU Y 104THR Y 109LEU Y 110 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A) U A1485 ( 4.7A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-4.6A)SFG Y 301 (-3.3A)SFG Y 301 (-4.0A) | 0.45A | 3mteA-4ox9Y:34.9 | 3mteA-4ox9Y:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_A_SAMA220_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 7 / 12 | GLY Y 32GLY Y 34PRO Y 56VAL Y 57ASN Y 60LEU Y 104THR Y 109 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A) U A1485 ( 4.7A) G A1486 ( 3.9A)SFG Y 301 (-4.6A)SFG Y 301 (-3.3A) | 0.58A | 3mteA-4ox9Y:34.9 | 3mteA-4ox9Y:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_A_SAMA220_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 7 / 12 | GLY Y 32PRO Y 56ALA Y 86ALA Y 87THR Y 109LEU Y 110SER Y 195 | SFG Y 301 (-3.9A)SFG Y 301 (-4.4A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-3.3A)SFG Y 301 (-4.0A)SFG Y 301 ( 3.7A) | 0.63A | 3mteA-4ox9Y:34.9 | 3mteA-4ox9Y:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_A_SAMA220_1 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 4 / 4 | ASN Y 38ASP Y 55GLU Y 88TRP Y 197 | SFG Y 301 ( 4.5A)SFG Y 301 (-2.8A)SFG Y 301 (-3.6A)SFG Y 301 (-3.5A) | 0.83A | 3mteA-4ox9Y:34.9 | 3mteA-4ox9Y:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_B_SAMB220_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 8 / 12 | GLY Y 32GLY Y 34ASN Y 38PRO Y 56VAL Y 57ALA Y 85LEU Y 104PHE Y 105 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 ( 4.5A)SFG Y 301 (-4.4A) U A1485 ( 4.7A)NoneSFG Y 301 (-4.6A)SFG Y 301 (-4.8A) | 1.49A | 3mteB-4ox9Y:34.2 | 3mteB-4ox9Y:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3MTE_B_SAMB220_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 12 / 12 | GLY Y 32GLY Y 34ASN Y 38PRO Y 56VAL Y 57ALA Y 86ALA Y 87GLU Y 88LEU Y 104PHE Y 105THR Y 109LEU Y 110 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 ( 4.5A)SFG Y 301 (-4.4A) U A1485 ( 4.7A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A)SFG Y 301 (-4.6A)SFG Y 301 (-4.8A)SFG Y 301 (-3.3A)SFG Y 301 (-4.0A) | 0.65A | 3mteB-4ox9Y:34.2 | 3mteB-4ox9Y:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N61_B_H4BB760_1 (NITRIC OXIDESYNTHASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 7 | PHE A 558SER A 486VAL A 511VAL A 508 | NoneNoneSFG A 700 ( 4.9A)None | 1.23A | 3n61A-4onqA:undetectable3n61B-4onqA:undetectable | 3n61A-4onqA:21.603n61B-4onqA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N62_A_ACTA860_0 (NITRIC OXIDESYNTHASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 4 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.35A | 3n62A-4onqA:0.0 | 3n62A-4onqA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N65_A_ACTA860_0 (NITRIC OXIDESYNTHASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 4 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.37A | 3n65A-4onqA:undetectable | 3n65A-4onqA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3N66_A_ACTA860_0 (NITRIC OXIDESYNTHASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 4 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.39A | 3n66A-4onqA:undetectable | 3n66A-4onqA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3NDU_D_ROCD100_1 (PROTEASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | ARG A 37GLY A 196VAL A 214GLY A 202ILE A 234 | NoneNoneNoneSFG A 491 (-4.1A)None | 0.94A | 3nduC-3n71A:undetectable | 3nduC-3n71A:10.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3O7W_A_SAMA801_0 (LEUCINE CARBOXYLMETHYLTRANSFERASE 1) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | GLY A 38GLY A 40ASP A 86LEU A 87VAL A 104 | SFG A1198 (-4.3A)SFG A1198 (-3.2A)SFG A1198 (-3.9A)SFG A1198 (-3.8A)SFG A1198 (-3.8A) | 0.41A | 3o7wA-2xvaA:11.2 | 3o7wA-2xvaA:22.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OOI_A_SAMA237_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.03A | 3ooiA-3n71A:5.8 | 3ooiA-3n71A:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OOI_A_SAMA237_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-36 AND H4LYSINE-20 SPECIFIC) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.40A | 3ooiA-3n71A:5.8 | 3ooiA-3n71A:18.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16ASN A 205HIS A 206TYR A 252CYH A 274 | NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.10A | 3opeA-3n71A:6.0 | 3opeA-3n71A:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.50A | 3opeA-3n71A:6.0 | 3opeA-3n71A:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.26A | 3opeA-3n71A:6.0 | 3opeA-3n71A:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OPE_A_SAMA7_0 (PROBABLEHISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.90A | 3opeA-3n71A:6.0 | 3opeA-3n71A:18.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3OU7_C_SAMC300_1 (SAM-DEPENDENTMETHYLTRANSFERASE) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 3 / 3 | GLY A 40ASP A 59ASP A 86 | SFG A1198 (-3.2A)SFG A1198 (-2.8A)SFG A1198 (-3.9A) | 0.16A | 3ou7C-2xvaA:15.1 | 3ou7C-2xvaA:24.78 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_A_SAMA6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 7 / 12 | GLY Y 32GLY Y 34ASN Y 38ALA Y 87PHE Y 105THR Y 109TRP Y 197 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 ( 4.5A)SFG Y 301 (-4.0A)SFG Y 301 (-4.8A)SFG Y 301 (-3.3A)SFG Y 301 (-3.5A) | 1.48A | 3p2kA-4ox9Y:31.7 | 3p2kA-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_A_SAMA6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 11 / 12 | GLY Y 32GLY Y 34ASN Y 38PRO Y 56ALA Y 86ALA Y 87LEU Y 104PHE Y 105THR Y 109LEU Y 110TRP Y 197 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 ( 4.5A)SFG Y 301 (-4.4A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-4.6A)SFG Y 301 (-4.8A)SFG Y 301 (-3.3A)SFG Y 301 (-4.0A)SFG Y 301 (-3.5A) | 0.70A | 3p2kA-4ox9Y:31.7 | 3p2kA-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_B_SAMB6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 11 / 12 | GLY Y 32GLY Y 34ASN Y 38PRO Y 56VAL Y 57ALA Y 87GLU Y 88LEU Y 104THR Y 109LEU Y 110TRP Y 197 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 ( 4.5A)SFG Y 301 (-4.4A) U A1485 ( 4.7A)SFG Y 301 (-4.0A)SFG Y 301 (-3.6A)SFG Y 301 (-4.6A)SFG Y 301 (-3.3A)SFG Y 301 (-4.0A)SFG Y 301 (-3.5A) | 0.73A | 3p2kB-4ox9Y:31.4 | 3p2kB-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_C_SAMC6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 11 / 12 | GLY Y 32GLY Y 34PRO Y 56VAL Y 57ASN Y 60ALA Y 86ALA Y 87LEU Y 104PHE Y 105LEU Y 110TRP Y 197 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A) U A1485 ( 4.7A) G A1486 ( 3.9A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-4.6A)SFG Y 301 (-4.8A)SFG Y 301 (-4.0A)SFG Y 301 (-3.5A) | 0.64A | 3p2kC-4ox9Y:31.6 | 3p2kC-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_C_SAMC6735_1 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 5 | ASN Y 38ASP Y 55GLU Y 88THR Y 109SER Y 195 | SFG Y 301 ( 4.5A)SFG Y 301 (-2.8A)SFG Y 301 (-3.6A)SFG Y 301 (-3.3A)SFG Y 301 ( 3.7A) | 0.81A | 3p2kC-4ox9Y:31.6 | 3p2kC-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_D_SAMD6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 6 / 12 | GLY Y 32GLY Y 34PRO Y 56VAL Y 57ALA Y 85LEU Y 104 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A) U A1485 ( 4.7A)NoneSFG Y 301 (-4.6A) | 1.26A | 3p2kD-4ox9Y:30.9 | 3p2kD-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_D_SAMD6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 10 / 12 | GLY Y 32GLY Y 34PRO Y 56VAL Y 57ALA Y 86ALA Y 87LEU Y 104LEU Y 110TYR Y 113TRP Y 197 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A) U A1485 ( 4.7A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-4.6A)SFG Y 301 (-4.0A)NoneSFG Y 301 (-3.5A) | 0.70A | 3p2kD-4ox9Y:30.9 | 3p2kD-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_D_SAMD6735_0 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 9 / 12 | GLY Y 32PRO Y 56ALA Y 86ALA Y 87LEU Y 104LEU Y 110TYR Y 113SER Y 195TRP Y 197 | SFG Y 301 (-3.9A)SFG Y 301 (-4.4A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.0A)SFG Y 301 (-4.6A)SFG Y 301 (-4.0A)NoneSFG Y 301 ( 3.7A)SFG Y 301 (-3.5A) | 1.11A | 3p2kD-4ox9Y:30.9 | 3p2kD-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P2K_D_SAMD6735_1 (16S RRNA METHYLASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 4 / 4 | ASN Y 38ASP Y 55GLU Y 88THR Y 109 | SFG Y 301 ( 4.5A)SFG Y 301 (-2.8A)SFG Y 301 (-3.6A)SFG Y 301 (-3.3A) | 0.64A | 3p2kD-4ox9Y:30.9 | 3p2kD-4ox9Y:98.65 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_A_SAMA263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.44A | 3p97A-3lkzA:41.1 | 3p97A-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_A_SAMA263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 3p97A-3lkzA:41.1 | 3p97A-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_A_SAMA263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 86TRP A 87LYS A 105HIS A 110ASP A 146ILE A 147 | SFG A 301 (-3.4A)SFG A 301 (-3.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 1.30A | 3p97A-3lkzA:41.1 | 3p97A-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_C_SAMC263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.49A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_C_SAMC263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.1A)SFG A 301 (-4.1A) | 0.84A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_C_SAMC263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A) | 1.15A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3P97_C_SAMC263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.38A | 3p97C-3lkzA:40.9 | 3p97C-3lkzA:60.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QOW_A_SAMA417_1 (HISTONE-LYSINEN-METHYLTRANSFERASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 3 / 3 | THR C 316ASP C 361GLU C 413 | SFG C1002 (-4.0A)SFG C1002 ( 4.9A)SFG C1002 (-2.8A) | 0.72A | 3qowA-5hr4C:9.3 | 3qowA-5hr4C:19.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QWP_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.15A | 3qwpA-3n71A:38.3 | 3qwpA-3n71A:30.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QWP_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.46A | 3qwpA-3n71A:38.3 | 3qwpA-3n71A:30.80 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3QWP_A_SAMA510_0 (SET AND MYNDDOMAIN-CONTAININGPROTEIN 3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.08A | 3qwpA-3n71A:38.3 | 3qwpA-3n71A:30.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QXY_A_SAMA6734_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.55A | 3qxyA-3n71A:12.6 | 3qxyA-3n71A:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3QXY_B_SAMB6735_0 (N-LYSINEMETHYLTRANSFERASESETD6TRANSCRIPTION FACTORP65) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)SFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.51A | 3qxyB-3n71A:12.73qxyQ-3n71A:undetectable | 3qxyB-3n71A:21.313qxyQ-3n71A:2.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RC0_A_SAMA484_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)SFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.48A | 3rc0A-3n71A:11.8 | 3rc0A-3n71A:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RC0_B_SAMB480_0 (N-LYSINEMETHYLTRANSFERASESETD6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.54A | 3rc0B-3n71A:12.6 | 3rc0B-3n71A:21.31 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3RQ4_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | ASN A 205HIS A 206TYR A 252PHE A 272CYH A 274 | SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) | 0.98A | 3rq4A-3n71A:7.2 | 3rq4A-3n71A:18.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S7B_A_SAMA1000_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.61A | 3s7bA-3n71A:39.2 | 3s7bA-3n71A:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S7F_A_SAMA1000_0 (N-LYSINEMETHYLTRANSFERASESMYD2P53 PEPTIDE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 12 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.62A | 3s7fA-3n71A:39.33s7fI-3n71A:undetectable | 3s7fA-3n71A:30.833s7fI-3n71A:2.53 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3S7J_A_SAMA1000_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.60A | 3s7jA-3n71A:38.9 | 3s7jA-3n71A:30.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S8P_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | ASN A 205HIS A 206TYR A 252PHE A 272CYH A 274 | SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) | 1.00A | 3s8pA-3n71A:6.0 | 3s8pA-3n71A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S8P_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252PHE A 272CYH A 274CYH A 276 | NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.09A | 3s8pA-3n71A:6.0 | 3s8pA-3n71A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3S8P_B_SAMB500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252PHE A 272CYH A 274CYH A 276 | NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.09A | 3s8pB-3n71A:7.1 | 3s8pB-3n71A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SGL_A_SAMA692_0 (TRNA5-METHYLAMINOMETHYL-2-THIOURIDINEBIOSYNTHESISBIFUNCTIONAL PROTEINMNMC) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | GLY A 38GLY A 40ASN A 44LYS A 60ASP A 86 | SFG A1198 (-4.3A)SFG A1198 (-3.2A)SFG A1198 (-3.9A)SFG A1198 (-3.3A)SFG A1198 (-3.9A) | 0.78A | 3sglA-2xvaA:9.7 | 3sglA-2xvaA:14.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3SGL_A_SAMA692_0 (TRNA5-METHYLAMINOMETHYL-2-THIOURIDINEBIOSYNTHESISBIFUNCTIONAL PROTEINMNMC) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 81GLY A 83LYS A 105ASP A 131VAL A 132 | SFG A 301 (-3.5A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.1A)SFG A 301 (-4.1A) | 0.88A | 3sglA-3lkzA:2.5 | 3sglA-3lkzA:16.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TG4_A_SAMA434_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 10 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.58A | 3tg4A-3n71A:39.2 | 3tg4A-3n71A:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TM4_A_SAMA401_0 (TRNA (GUANINEN2-)-METHYLTRANSFERASE TRM14) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 12 / 12 | ALA A 200HIS A 201LEU A 202MET A 225GLY A 227LYS A 249TYR A 250HIS A 253ALA A 277ASN A 293PRO A 295LEU A 309 | SFG A 401 (-3.9A)NoneSFG A 401 (-4.5A)SFG A 401 (-3.9A)SFG A 401 ( 3.7A)SFG A 401 (-4.9A)SFG A 401 (-4.5A)SFG A 401 (-3.9A)SFG A 401 (-3.1A)SFG A 401 (-4.4A)SFG A 401 ( 4.4A)None | 0.25A | 3tm4A-3tm5A:54.6 | 3tm4A-3tm5A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TM4_A_SAMA401_1 (TRNA (GUANINEN2-)-METHYLTRANSFERASE TRM14) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 5 | HIS A 198SER A 228THR A 230GLU A 248ASP A 276 | SFG A 401 (-3.8A)SFG A 401 (-3.6A)SFG A 401 (-3.3A)SFG A 401 (-2.6A)SFG A 401 (-3.4A) | 0.36A | 3tm4A-3tm5A:54.6 | 3tm4A-3tm5A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TM4_B_SAMB401_0 (TRNA (GUANINEN2-)-METHYLTRANSFERASE TRM14) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 12 / 12 | ALA A 200HIS A 201LEU A 202MET A 225GLY A 227LYS A 249TYR A 250HIS A 253ALA A 277ASN A 293PRO A 295LEU A 309 | SFG A 401 (-3.9A)NoneSFG A 401 (-4.5A)SFG A 401 (-3.9A)SFG A 401 ( 3.7A)SFG A 401 (-4.9A)SFG A 401 (-4.5A)SFG A 401 (-3.9A)SFG A 401 (-3.1A)SFG A 401 (-4.4A)SFG A 401 ( 4.4A)None | 0.24A | 3tm4B-3tm5A:55.1 | 3tm4B-3tm5A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3TM4_B_SAMB401_1 (TRNA (GUANINEN2-)-METHYLTRANSFERASE TRM14) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 5 | HIS A 198SER A 228THR A 230GLU A 248ASP A 276 | SFG A 401 (-3.8A)SFG A 401 (-3.6A)SFG A 401 (-3.3A)SFG A 401 (-2.6A)SFG A 401 (-3.4A) | 0.39A | 3tm4B-3tm5A:55.1 | 3tm4B-3tm5A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V8V_A_SAMA801_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE L) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 7 / 12 | MET A 225GLY A 227SER A 228THR A 230ASN A 293PRO A 295LEU A 309 | SFG A 401 (-3.9A)SFG A 401 ( 3.7A)SFG A 401 (-3.6A)SFG A 401 (-3.3A)SFG A 401 (-4.4A)SFG A 401 ( 4.4A)None | 0.67A | 3v8vA-3tm5A:31.1 | 3v8vA-3tm5A:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V8V_B_SAMB801_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE L) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 11 | ASP A 291ASP A 293ASP A 318PRO A 339LEU A 367 | SFG A5748 (-2.9A)NoneSFG A5748 (-3.7A)SFG A5748 (-4.0A)None | 1.19A | 3v8vB-2yxlA:13.4 | 3v8vB-2yxlA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V8V_B_SAMB801_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE L) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 11 | ASP A 291ASP A 293ASP A 318PRO A 339LEU A 371 | SFG A5748 (-2.9A)NoneSFG A5748 (-3.7A)SFG A5748 (-4.0A)None | 1.10A | 3v8vB-2yxlA:13.4 | 3v8vB-2yxlA:21.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3V8V_B_SAMB801_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE L) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 11 | MET A 225GLY A 227ASP A 276ASN A 293PRO A 295LEU A 309 | SFG A 401 (-3.9A)SFG A 401 ( 3.7A)SFG A 401 (-3.4A)SFG A 401 (-4.4A)SFG A 401 ( 4.4A)None | 0.59A | 3v8vB-3tm5A:27.7 | 3v8vB-3tm5A:18.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3VYW_C_SAMC401_0 (MNMC2) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | GLY Y 32GLY Y 36ASN Y 38ALA Y 87LEU Y 110 | SFG Y 301 (-3.9A)NoneSFG Y 301 ( 4.5A)SFG Y 301 (-4.0A)SFG Y 301 (-4.0A) | 1.08A | 3vywC-4ox9Y:7.1 | 3vywC-4ox9Y:21.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3WDM_A_ADNA901_1 (4-PHOSPHOPANTOATE--BETA-ALANINE LIGASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 9 | GLY Y 34LEU Y 31ASP Y 30ASN Y 38ILE Y 54 | SFG Y 301 (-3.1A)NoneSFG Y 301 ( 4.7A)SFG Y 301 ( 4.5A)None | 1.20A | 3wdmA-4ox9Y:undetectable | 3wdmA-4ox9Y:22.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B17_A_SAMA1358_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE M) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 6 / 12 | PRO A 270GLY A 271GLY A 272ASP A 291ASP A 318ASP A 337 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.75A | 4b17A-2yxlA:10.5 | 4b17A-2yxlA:25.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4B17_A_SAMA1358_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE M) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | SER A 56GLY A 81GLY A 85GLY A 86TRP A 87ASP A 131ASP A 146 | SFG A 301 (-2.6A)SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-3.8A) | 0.62A | 4b17A-3lkzA:13.0 | 4b17A-3lkzA:21.30 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BLV_B_SAMB1281_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE J) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | ASP A 79GLY A 83GLY A 86HIS A 110ASP A 146 | SFG A 301 ( 4.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.9A)SFG A 301 (-3.8A) | 1.21A | 4blvB-3lkzA:undetectable | 4blvB-3lkzA:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | ASN A 205HIS A 206TYR A 252PHE A 272CYH A 274 | SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) | 1.04A | 4bupA-3n71A:5.9 | 4bupA-3n71A:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_A_SAMA500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252PHE A 272CYH A 274CYH A 276 | NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.06A | 4bupA-3n71A:5.9 | 4bupA-3n71A:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4BUP_B_SAMB500_0 (HISTONE-LYSINEN-METHYLTRANSFERASESUV420H1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252PHE A 272CYH A 274CYH A 276 | NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.09A | 4bupB-3n71A:7.5 | 4bupB-3n71A:19.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4C9K_B_CAMB424_0 (CYTOCHROME P450) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 9 | THR A 136LEU A 124GLY A 95THR A 99VAL A 133 | NoneNoneSFG A 500 (-4.0A)NoneNone | 1.38A | 4c9kB-3a4tA:undetectable | 4c9kB-3a4tA:20.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_A_SAMA1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.45A | 4ctjA-3lkzA:41.3 | 4ctjA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_A_SAMA1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.89A | 4ctjA-3lkzA:41.3 | 4ctjA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_A_SAMA1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 4ctjA-3lkzA:41.3 | 4ctjA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_C_SAMC1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86THR A 104LYS A 105HIS A 110VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A) | 0.89A | 4ctjC-3lkzA:41.0 | 4ctjC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_C_SAMC1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.42A | 4ctjC-3lkzA:41.0 | 4ctjC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_C_SAMC1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A) | 1.19A | 4ctjC-3lkzA:41.0 | 4ctjC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_C_SAMC1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 58GLY A 83GLY A 86TRP A 87THR A 104GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.88A | 4ctjC-3lkzA:41.0 | 4ctjC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTJ_C_SAMC1263_0 (NON-STRUCTURALPROTEIN 5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 4ctjC-3lkzA:41.0 | 4ctjC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTK_A_SAMA1263_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.42A | 4ctkA-3lkzA:41.2 | 4ctkA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTK_A_SAMA1263_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.36A | 4ctkA-3lkzA:41.2 | 4ctkA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTK_C_SAMC1263_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 4ctkC-3lkzA:40.9 | 4ctkC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTK_C_SAMC1263_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.36A | 4ctkC-3lkzA:40.9 | 4ctkC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4CTK_C_SAMC1263_0 (POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | SER A 56GLY A 58GLY A 83GLY A 86THR A 104GLU A 111VAL A 132 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.94A | 4ctkC-3lkzA:40.9 | 4ctkC-3lkzA:54.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D33_A_ACTA860_0 (NITRIC OXIDESYNTHASE,ENDOTHELIAL) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 5 | GLY A 492ILE A 491VAL A 464SER A 461 | SFG A 700 ( 4.9A)SFG A 700 (-4.1A)NoneSFG A 700 (-2.9A) | 1.01A | 4d33A-4onqA:undetectable | 4d33A-4onqA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D33_B_ACTB860_0 (NITRIC OXIDESYNTHASE,ENDOTHELIAL) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 5 | GLY A 492ILE A 491VAL A 464SER A 461 | SFG A 700 ( 4.9A)SFG A 700 (-4.1A)NoneSFG A 700 (-2.9A) | 1.02A | 4d33B-4onqA:undetectable | 4d33B-4onqA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4D39_B_ACTB860_0 (NITRIC OXIDESYNTHASE,ENDOTHELIAL) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 6 | GLY A 492ILE A 491VAL A 464SER A 461 | SFG A 700 ( 4.9A)SFG A 700 (-4.1A)NoneSFG A 700 (-2.9A) | 1.01A | 4d39B-4onqA:undetectable | 4d39B-4onqA:22.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DMG_A_SAMA401_0 (PUTATIVEUNCHARACTERIZEDPROTEIN TTHA1493) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | ASP A 291ASP A 293ALA A 319ASP A 337PRO A 339 | SFG A5748 (-2.9A)NoneSFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-4.0A) | 0.65A | 4dmgA-2yxlA:14.4 | 4dmgA-2yxlA:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4DMG_B_SAMB401_0 (PUTATIVEUNCHARACTERIZEDPROTEIN TTHA1493) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 11 | ASP A 291ASP A 293ALA A 319ASP A 337PRO A 339 | SFG A5748 (-2.9A)NoneSFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-4.0A) | 0.76A | 4dmgB-2yxlA:14.5 | 4dmgB-2yxlA:25.54 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E47_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.62A | 4e47A-3n71A:6.4 | 4e47A-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E47_B_SAMB800_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.60A | 4e47B-3n71A:5.7 | 4e47B-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4E47_C_SAMC800_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.61A | 4e47C-3n71A:6.4 | 4e47C-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_A_SAMA401_0 (METHYLTRANSFERASENSUN4) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | PRO A 270GLY A 271GLY A 272LYS A 273ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.32A | 4fp9A-2yxlA:28.2 | 4fp9A-2yxlA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_A_SAMA401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 6 / 12 | CYH A 91GLY A 95LYS A 97ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-4.0A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 1.05A | 4fp9A-3a4tA:26.3 | 4fp9A-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_A_SAMA401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 9 / 12 | CYH A 91PRO A 94GLY A 95GLY A 96LYS A 97SER A 117ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 0.50A | 4fp9A-3a4tA:26.3 | 4fp9A-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_C_SAMC401_0 (METHYLTRANSFERASENSUN4) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | PRO A 270GLY A 271GLY A 272LYS A 273ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.30A | 4fp9C-2yxlA:28.2 | 4fp9C-2yxlA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_C_SAMC401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 6 / 12 | CYH A 91GLY A 95LYS A 97ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-4.0A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 1.02A | 4fp9C-3a4tA:26.3 | 4fp9C-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_C_SAMC401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 9 / 12 | CYH A 91PRO A 94GLY A 95GLY A 96LYS A 97SER A 117ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 0.50A | 4fp9C-3a4tA:26.3 | 4fp9C-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_D_SAMD401_0 (METHYLTRANSFERASENSUN4) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | PRO A 270GLY A 271GLY A 272LYS A 273ASP A 318PRO A 339LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.7A)SFG A5748 (-4.0A)None | 0.40A | 4fp9D-2yxlA:28.3 | 4fp9D-2yxlA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_D_SAMD401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | CYH A 91GLY A 95LYS A 97PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-4.0A)SFG A 500 (-2.8A)SFG A 500 (-3.9A)None | 1.06A | 4fp9D-3a4tA:26.4 | 4fp9D-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_D_SAMD401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 9 / 12 | CYH A 91PRO A 94GLY A 95GLY A 96LYS A 97SER A 117ASP A 142PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-4.0A)SFG A 500 (-3.9A)None | 0.68A | 4fp9D-3a4tA:26.4 | 4fp9D-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_F_SAMF401_0 (METHYLTRANSFERASENSUN4) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | PRO A 270GLY A 271GLY A 272LYS A 273ASP A 337PRO A 339LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.6A)SFG A5748 (-4.0A)None | 0.32A | 4fp9F-2yxlA:28.1 | 4fp9F-2yxlA:25.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_F_SAMF401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 6 / 12 | CYH A 91GLY A 95LYS A 97ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-4.0A)SFG A 500 (-2.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 1.02A | 4fp9F-3a4tA:26.3 | 4fp9F-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FP9_F_SAMF401_0 (METHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 9 / 12 | CYH A 91PRO A 94GLY A 95GLY A 96LYS A 97SER A 117ASP A 163PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-3.7A)SFG A 500 (-3.9A)None | 0.49A | 4fp9F-3a4tA:26.3 | 4fp9F-3a4tA:25.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FZV_A_SAMA401_0 (PUTATIVEMETHYLTRANSFERASENSUN4) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | PRO A 270GLY A 271GLY A 272LYS A 273ASP A 318PRO A 339LEU A 371 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.7A)SFG A5748 (-4.0A)None | 0.36A | 4fzvA-2yxlA:28.1 | 4fzvA-2yxlA:25.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4FZV_A_SAMA401_0 (PUTATIVEMETHYLTRANSFERASENSUN4) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 9 / 12 | CYH A 91PRO A 94GLY A 95GLY A 96LYS A 97SER A 117ASP A 142PRO A 165LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-4.0A)SFG A 500 (-3.9A)None | 0.69A | 4fzvA-3a4tA:26.1 | 4fzvA-3a4tA:24.80 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GC9_A_SAMA401_0 (DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | GLY A 227ILE A 231ASN A 293LEU A 294PRO A 295 | SFG A 401 ( 3.7A)NoneSFG A 401 (-4.4A)NoneSFG A 401 ( 4.4A) | 0.96A | 4gc9A-3tm5A:11.2 | 4gc9A-3tm5A:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4GC9_A_SAMA401_0 (DIMETHYLADENOSINETRANSFERASE 1,MITOCHONDRIAL) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 12 | LEU A 202GLY A 227ILE A 231LYS A 249ASN A 293PRO A 295 | SFG A 401 (-4.5A)SFG A 401 ( 3.7A)NoneSFG A 401 (-4.9A)SFG A 401 (-4.4A)SFG A 401 ( 4.4A) | 0.90A | 4gc9A-3tm5A:11.2 | 4gc9A-3tm5A:24.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | ARG A 19LEU A 203ASN A 205HIS A 206TYR A 252 | SFG A 491 (-3.9A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.51A | 4ij8A-3n71A:6.44ij8B-3n71A:6.8 | 4ij8A-3n71A:15.454ij8B-3n71A:15.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | LYS A 17ARG A 19ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.64A | 4ij8A-3n71A:6.44ij8B-3n71A:6.8 | 4ij8A-3n71A:15.454ij8B-3n71A:15.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | LYS A 17LEU A 21ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 1.19A | 4ij8A-3n71A:6.44ij8B-3n71A:6.8 | 4ij8A-3n71A:15.454ij8B-3n71A:15.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4IJ8_B_SAMB501_0 (N-LYSINEMETHYLTRANSFERASESETD8) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 9 | LYS A 17ARG A 19ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.67A | 4ij8A-3n71A:6.44ij8B-3n71A:6.8 | 4ij8A-3n71A:15.454ij8B-3n71A:15.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JDS_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.60A | 4jdsA-3n71A:7.3 | 4jdsA-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JDS_B_SAMB401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.61A | 4jdsB-3n71A:6.4 | 4jdsB-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JDS_C_SAMC401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.60A | 4jdsC-3n71A:7.3 | 4jdsC-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4JLG_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.64A | 4jlgA-3n71A:6.0 | 4jlgA-3n71A:17.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N48_B_SAMB601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 4 / 5 | PRO A 270GLY A 272ASP A 318ASP A 337 | SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.51A | 4n48B-2yxlA:10.6 | 4n48B-2yxlA:21.55 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4N48_B_SAMB601_1 (CAP-SPECIFIC MRNA(NUCLEOSIDE-2'-O-)-METHYLTRANSFERASE 1) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 4 / 5 | PRO A 94GLY A 96ASP A 142ASP A 163 | SFG A 500 (-3.9A)SFG A 500 (-3.5A)SFG A 500 (-4.0A)SFG A 500 (-3.7A) | 0.46A | 4n48B-3a4tA:9.6 | 4n48B-3a4tA:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJV_A_RITA500_1 (PROTEASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | ARG A 37GLY A 196VAL A 214GLY A 202ILE A 234 | NoneNoneNoneSFG A 491 (-4.1A)None | 0.95A | 4njvA-3n71A:undetectable | 4njvA-3n71A:14.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJV_A_RITA500_2 (PROTEASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | ARG A 37GLY A 196VAL A 214GLY A 202ILE A 234 | NoneNoneNoneSFG A 491 (-4.1A)None | 0.95A | 4njvB-3n71A:undetectable | 4njvB-3n71A:14.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4NJV_D_RITD500_1 (PROTEASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | ARG A 37GLY A 196VAL A 214GLY A 202ILE A 234 | NoneNoneNoneSFG A 491 (-4.1A)None | 0.96A | 4njvC-3n71A:undetectable | 4njvC-3n71A:14.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCK_A_SAMA2409_1 (RNA-DIRECTED RNAPOLYMERASE L) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 3 / 3 | SER A 56ASP A 131ASP A 146 | SFG A 301 (-2.6A)SFG A 301 (-3.1A)SFG A 301 (-3.8A) | 0.56A | 4uckA-3lkzA:8.8 | 4uckA-3lkzA:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4UCK_B_SAMB2409_1 (RNA-DIRECTED RNAPOLYMERASE L) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 4 / 6 | SER A 56GLY A 81ASP A 131ASP A 146 | SFG A 301 (-2.6A)SFG A 301 (-3.5A)SFG A 301 (-3.1A)SFG A 301 (-3.8A) | 0.56A | 4uckB-3lkzA:9.5 | 4uckB-3lkzA:19.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4V32_C_EF2C151_1 (CEREBLON ISOFORM 4) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 4 / 7 | ASN C 481PRO C 482PHE C 535PHE C 563 | SFG C1002 (-3.8A)NoneNoneNone | 1.49A | 4v32C-5hr4C:undetectable | 4v32C-5hr4C:9.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4XE0_A_40LA1101_0 (PHOSPHATIDYLINOSITOL4,5-BISPHOSPHATE3-KINASE CATALYTICSUBUNIT DELTAISOFORM) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 5 / 12 | ILE Y 68VAL Y 81ASP Y 55THR Y 33ILE Y 39 | NoneNoneSFG Y 301 (-2.8A)NoneNone | 1.38A | 4xe0A-4ox9Y:undetectable | 4xe0A-4ox9Y:14.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YND_A_SAMA505_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 10 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.64A | 4yndA-3n71A:37.6 | 4yndA-3n71A:29.78 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNM_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.32A | 4ynmA-3n71A:6.1 | 4ynmA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNM_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.83A | 4ynmA-3n71A:6.1 | 4ynmA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNM_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16ASN A 205HIS A 206TYR A 252CYH A 274 | NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.12A | 4ynmB-3n71A:6.1 | 4ynmB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNM_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.40A | 4ynmB-3n71A:6.1 | 4ynmB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.96A | 4ynpA-3n71A:6.0 | 4ynpA-3n71A:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.32A | 4ynpA-3n71A:6.0 | 4ynpA-3n71A:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.97A | 4ynpA-3n71A:6.0 | 4ynpA-3n71A:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.32A | 4ynpA-3n71A:6.0 | 4ynpA-3n71A:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YNP_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.32A | 4ynpB-3n71A:6.2 | 4ynpB-3n71A:17.81 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_A_SAMA3004_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.31A | 4ypaA-3n71A:6.0 | 4ypaA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_A_SAMA3004_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.85A | 4ypaA-3n71A:6.0 | 4ypaA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.31A | 4ypaB-3n71A:6.1 | 4ypaB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.74A | 4ypaB-3n71A:6.1 | 4ypaB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_C_SAMC2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.34A | 4ypaC-3n71A:6.0 | 4ypaC-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_C_SAMC2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.79A | 4ypaC-3n71A:6.0 | 4ypaC-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_D_SAMD2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.32A | 4ypaD-3n71A:6.0 | 4ypaD-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPA_D_SAMD2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.75A | 4ypaD-3n71A:6.0 | 4ypaD-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.35A | 4ypeA-3n71A:6.1 | 4ypeA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.81A | 4ypeA-3n71A:6.1 | 4ypeA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPE_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.36A | 4ypeB-3n71A:6.3 | 4ypeB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPE_B_SAMB2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 11 | LYS A 17GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.80A | 4ypeB-3n71A:6.3 | 4ypeB-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPU_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16ASN A 205HIS A 206TYR A 252CYH A 274 | NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.11A | 4ypuA-3n71A:6.1 | 4ypuA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPU_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.41A | 4ypuA-3n71A:6.1 | 4ypuA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPU_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.33A | 4ypuA-3n71A:6.1 | 4ypuA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YPU_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.97A | 4ypuA-3n71A:6.1 | 4ypuA-3n71A:18.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4YVG_A_SAMA301_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 12 / 12 | LEU A 92SER A 93PRO A 94GLY A 118GLU A 121GLY A 122SER A 137ILE A 138LEU A 143GLY A 145GLY A 146PRO A 149 | SFG A 400 (-4.6A)NoneSFG A 400 (-3.7A)SFG A 400 (-3.4A)SFG A 400 (-4.1A)SFG A 400 (-3.6A)SFG A 400 (-3.3A)SFG A 400 (-4.4A)SFG A 400 (-4.2A)SFG A 400 (-3.2A)SFG A 400 (-3.7A)SFG A 400 (-4.4A) | 0.32A | 4yvgA-5wyrA:30.2 | 4yvgA-5wyrA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ARF_A_SAMA1002_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 270PHE A 272 | SFG A 491 (-4.7A)NoneNoneNoneSFG A 491 (-3.7A) | 1.47A | 5arfA-3n71A:39.0 | 5arfA-3n71A:30.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ARF_A_SAMA1002_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 12 | LYS A 17GLY A 18ARG A 19HIS A 135ASN A 180HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.66A | 5arfA-3n71A:39.0 | 5arfA-3n71A:30.63 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ARG_A_SAMA1434_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.71A | 5argA-3n71A:39.2 | 5argA-3n71A:30.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5AYF_A_SAMA401_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD7) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.61A | 5ayfA-3n71A:6.3 | 5ayfA-3n71A:17.98 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BW4_A_SAMA301_0 (16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 7 / 12 | GLY Y 32GLY Y 34ASP Y 55PRO Y 56GLU Y 88LEU Y 104LEU Y 110 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-2.8A)SFG Y 301 (-4.4A)SFG Y 301 (-3.6A)SFG Y 301 (-4.6A)SFG Y 301 (-4.0A) | 0.48A | 5bw4A-4ox9Y:26.3 | 5bw4A-4ox9Y:27.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5BW4_B_SAMB301_0 (16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE) |
4ox9 | 16S RRNA(ADENINE(1408)-N(1))-METHYLTRANSFERASE (Escherichiacoli) | 6 / 12 | GLY Y 32GLY Y 34PRO Y 56ALA Y 86LEU Y 104LEU Y 110 | SFG Y 301 (-3.9A)SFG Y 301 (-3.1A)SFG Y 301 (-4.4A)SFG Y 301 ( 4.1A)SFG Y 301 (-4.6A)SFG Y 301 (-4.0A) | 0.58A | 5bw4B-4ox9Y:27.5 | 5bw4B-4ox9Y:27.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CCL_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.17A | 5cclA-3n71A:37.9 | 5cclA-3n71A:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CCL_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.47A | 5cclA-3n71A:37.9 | 5cclA-3n71A:29.96 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5CCL_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.10A | 5cclA-3n71A:37.9 | 5cclA-3n71A:29.96 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCM_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.18A | 5ccmA-3n71A:38.1 | 5ccmA-3n71A:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCM_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.45A | 5ccmA-3n71A:38.1 | 5ccmA-3n71A:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5CCM_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.09A | 5ccmA-3n71A:38.1 | 5ccmA-3n71A:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5E9Q_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.40A | 5e9qA-3lkzA:41.0 | 5e9qA-3lkzA:57.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5E9Q_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.50A | 5e9qA-3lkzA:41.0 | 5e9qA-3lkzA:57.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5E9Q_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5e9qA-3lkzA:41.0 | 5e9qA-3lkzA:57.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5E9Q_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.55A | 5e9qC-3lkzA:41.0 | 5e9qC-3lkzA:57.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5E9Q_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5e9qC-3lkzA:41.0 | 5e9qC-3lkzA:57.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EC8_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.36A | 5ec8A-3lkzA:40.9 | 5ec8A-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EC8_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.57A | 5ec8A-3lkzA:40.9 | 5ec8A-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EC8_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.46A | 5ec8C-3lkzA:40.6 | 5ec8C-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EC8_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58GLY A 83GLY A 86TRP A 87THR A 104GLU A 111VAL A 132ASP A 146 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A) | 0.76A | 5ec8C-3lkzA:40.6 | 5ec8C-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EC8_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5ec8C-3lkzA:40.6 | 5ec8C-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHG_A_SAMA301_0 (RNA-DIRECTED RNAPOLYMERASE NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.53A | 5ehgA-3lkzA:41.0 | 5ehgA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHG_A_SAMA301_0 (RNA-DIRECTED RNAPOLYMERASE NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5ehgA-3lkzA:41.0 | 5ehgA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHG_C_SAMC4001_0 (RNA-DIRECTED RNAPOLYMERASE NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.36A | 5ehgC-3lkzA:40.8 | 5ehgC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHG_C_SAMC4001_0 (RNA-DIRECTED RNAPOLYMERASE NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.38A | 5ehgC-3lkzA:40.8 | 5ehgC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHG_C_SAMC4001_0 (RNA-DIRECTED RNAPOLYMERASE NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 86TRP A 87HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 1.43A | 5ehgC-3lkzA:40.8 | 5ehgC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHI_A_SAMA4001_0 (NS5METHYLTRANSFERASEDENGUE VIRUS) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.39A | 5ehiA-3lkzA:41.1 | 5ehiA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHI_A_SAMA4001_0 (NS5METHYLTRANSFERASEDENGUE VIRUS) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.41A | 5ehiA-3lkzA:41.1 | 5ehiA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EHI_A_SAMA4001_0 (NS5METHYLTRANSFERASEDENGUE VIRUS) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 58GLY A 83GLY A 86THR A 104GLU A 111 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A) | 0.93A | 5ehiA-3lkzA:41.1 | 5ehiA-3lkzA:54.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EHI_C_SAMC4000_0 (NS5METHYLTRANSFERASEDENGUE VIRUS) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.47A | 5ehiC-3lkzA:41.1 | 5ehiC-3lkzA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EHI_C_SAMC4000_0 (NS5METHYLTRANSFERASEDENGUE VIRUS) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.64A | 5ehiC-3lkzA:41.1 | 5ehiC-3lkzA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EHI_C_SAMC4000_0 (NS5METHYLTRANSFERASEDENGUE VIRUS) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A) | 1.06A | 5ehiC-3lkzA:41.1 | 5ehiC-3lkzA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIF_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.47A | 5eifA-3lkzA:41.2 | 5eifA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIF_A_SAMA301_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5eifA-3lkzA:41.2 | 5eifA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIF_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.48A | 5eifC-3lkzA:41.0 | 5eifC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIF_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.72A | 5eifC-3lkzA:41.0 | 5eifC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIF_C_SAMC4000_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5eifC-3lkzA:41.0 | 5eifC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.24A | 5eiwA-3lkzA:41.1 | 5eiwA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A) | 0.41A | 5eiwA-3lkzA:41.1 | 5eiwA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.30A | 5eiwA-3lkzA:41.1 | 5eiwA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-3.8A) | 0.36A | 5eiwA-3lkzA:41.1 | 5eiwA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | GLY A 58GLY A 83GLY A 86THR A 104GLU A 111 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)SFG A 301 (-3.7A) | 0.86A | 5eiwA-3lkzA:41.1 | 5eiwA-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_C_SAMC4000_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.43A | 5eiwC-3lkzA:41.0 | 5eiwC-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EIW_C_SAMC4000_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5eiwC-3lkzA:41.0 | 5eiwC-3lkzA:54.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EKX_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.37A | 5ekxA-3lkzA:41.2 | 5ekxA-3lkzA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5EKX_A_SAMA301_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | SER A 56GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.6A)SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.40A | 5ekxA-3lkzA:41.2 | 5ekxA-3lkzA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EKX_B_SAMB4000_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.43A | 5ekxB-3lkzA:41.2 | 5ekxB-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EKX_B_SAMB4000_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 58GLY A 83GLY A 86THR A 104LYS A 105GLU A 111VAL A 132 | SFG A 301 (-2.9A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.83A | 5ekxB-3lkzA:41.2 | 5ekxB-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EKX_B_SAMB4000_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5ekxB-3lkzA:41.2 | 5ekxB-3lkzA:54.86 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5EKX_B_SAMB4000_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 86TRP A 87HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 1.49A | 5ekxB-3lkzA:41.2 | 5ekxB-3lkzA:54.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5FA8_A_SAMA301_1 (RIBOSOMAL PROTEINL11METHYLTRANSFERASE,PUTATIVE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 3 / 3 | THR C 316ASP C 361GLU C 413 | SFG C1002 (-4.0A)SFG C1002 ( 4.9A)SFG C1002 (-2.8A) | 0.54A | 5fa8A-5hr4C:11.0 | 5fa8A-5hr4C:10.62 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_A_SAMA301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 12 | ASP A 276ALA A 277PRO A 295GLY A 227THR A 230GLU A 248 | SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 ( 3.7A)SFG A 401 (-3.3A)SFG A 401 (-2.6A) | 0.58A | 5hfjA-3tm5A:3.5 | 5hfjA-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_A_SAMA301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | ALA C 461PRO C 483GLY C 365GLU C 413GLU C 415 | SFG C1002 (-3.8A)SFG C1002 (-4.1A)SFG C1002 (-3.4A)SFG C1002 (-2.8A)None | 0.53A | 5hfjA-5hr4C:undetectable | 5hfjA-5hr4C:13.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_B_SAMB301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 12 | ALA A 277PRO A 295HIS A 198GLY A 227SER A 228THR A 230 | SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 (-3.8A)SFG A 401 ( 3.7A)SFG A 401 (-3.6A)SFG A 401 (-3.3A) | 0.65A | 5hfjB-3tm5A:3.3 | 5hfjB-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_C_SAMC301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | ASP A 276ALA A 277PRO A 295GLY A 227THR A 230 | SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 ( 3.7A)SFG A 401 (-3.3A) | 0.66A | 5hfjC-3tm5A:3.5 | 5hfjC-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_D_SAMD301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 7 / 12 | ASP A 276ALA A 277PRO A 295GLY A 227SER A 228THR A 230GLU A 248 | SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 ( 3.7A)SFG A 401 (-3.6A)SFG A 401 (-3.3A)SFG A 401 (-2.6A) | 0.78A | 5hfjD-3tm5A:3.6 | 5hfjD-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_D_SAMD301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | ALA C 461PRO C 483GLY C 365GLU C 413GLU C 415 | SFG C1002 (-3.8A)SFG C1002 (-4.1A)SFG C1002 (-3.4A)SFG C1002 (-2.8A)None | 0.62A | 5hfjD-5hr4C:2.6 | 5hfjD-5hr4C:13.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_E_SAME301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | ALA A 322ASP A 291PRO A 339PHE A 290SER A 374 | NoneSFG A5748 (-2.9A)SFG A5748 (-4.0A)NoneNone | 1.08A | 5hfjE-2yxlA:2.9 | 5hfjE-2yxlA:20.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_E_SAME301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 12 | ASP A 276ALA A 277GLY A 227SER A 228THR A 230GLU A 248 | SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 ( 3.7A)SFG A 401 (-3.6A)SFG A 401 (-3.3A)SFG A 401 (-2.6A) | 0.57A | 5hfjE-3tm5A:5.8 | 5hfjE-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_F_SAMF301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 6 / 12 | ASP A 276ALA A 277PRO A 295GLY A 227SER A 228GLU A 248 | SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 ( 3.7A)SFG A 401 (-3.6A)SFG A 401 (-2.6A) | 0.67A | 5hfjF-3tm5A:3.4 | 5hfjF-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_F_SAMF301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | ASP A 276PRO A 224GLY A 227SER A 228GLU A 248 | SFG A 401 (-3.4A)NoneSFG A 401 ( 3.7A)SFG A 401 (-3.6A)SFG A 401 (-2.6A) | 1.27A | 5hfjF-3tm5A:3.4 | 5hfjF-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_G_SAMG301_1 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 4 / 4 | ASP A 276HIS A 198SER A 228GLU A 248 | SFG A 401 (-3.4A)SFG A 401 (-3.8A)SFG A 401 (-3.6A)SFG A 401 (-2.6A) | 0.64A | 5hfjG-3tm5A:3.4 | 5hfjG-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HFJ_H_SAMH301_0 (ADENINE SPECIFIC DNAMETHYLTRANSFERASE(DPNA)) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 12 | ASP A 276ALA A 277PRO A 295GLY A 227THR A 230 | SFG A 401 (-3.4A)SFG A 401 (-3.1A)SFG A 401 ( 4.4A)SFG A 401 ( 3.7A)SFG A 401 (-3.3A) | 0.66A | 5hfjH-3tm5A:4.0 | 5hfjH-3tm5A:23.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5HJI_A_ADNA401_1 (TRNA(GUANINE(37)-N1)-METHYLTRANSFERASE TRM5A) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 5 / 11 | PHE A 488GLY A 490GLU A 512ASP A 539VAL A 540 | SFG A 700 (-4.5A)SFG A 700 (-3.5A)SFG A 700 (-2.1A)SFG A 700 ( 4.4A)SFG A 700 (-4.2A) | 0.67A | 5hjiA-4onqA:6.1 | 5hjiA-4onqA:23.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKM_A_SAMA311_0 (NS5 METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.32A | 5ikmA-3lkzA:41.1 | 5ikmA-3lkzA:62.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKM_A_SAMA311_0 (NS5 METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.34A | 5ikmA-3lkzA:41.1 | 5ikmA-3lkzA:62.27 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5IKM_A_SAMA311_0 (NS5 METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 83GLY A 86THR A 104LYS A 105VAL A 132 | SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A) | 0.95A | 5ikmA-3lkzA:41.1 | 5ikmA-3lkzA:62.27 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5IKM_A_SAMA311_0 (NS5 METHYLTRANSFERASE) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 5 / 12 | GLY A 490GLY A 493LYS A 513ASP A 539VAL A 540 | SFG A 700 (-3.5A)SFG A 700 (-3.6A)SFG A 700 (-3.4A)SFG A 700 ( 4.4A)SFG A 700 (-4.2A) | 0.89A | 5ikmA-4onqA:3.0 | 5ikmA-4onqA:22.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JHN_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.51A | 5jhnA-3n71A:5.7 | 5jhnA-3n71A:19.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JHN_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.53A | 5jhnB-3n71A:5.7 | 5jhnB-3n71A:19.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JIY_A_SAMA1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.51A | 5jiyA-3n71A:5.6 | 5jiyA-3n71A:19.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JIY_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.53A | 5jiyB-3n71A:5.7 | 5jiyB-3n71A:19.14 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5JJ0_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.56A | 5jj0B-3n71A:5.7 | 5jj0B-3n71A:19.14 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJK_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.61A | 5kjkA-3n71A:39.2 | 5kjkA-3n71A:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJL_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.62A | 5kjlA-3n71A:39.1 | 5kjlA-3n71A:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJM_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.61A | 5kjmA-3n71A:39.3 | 5kjmA-3n71A:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KJN_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 9 / 11 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.69A | 5kjnA-3n71A:39.2 | 5kjnA-3n71A:30.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KQR_A_SAMA301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110GLU A 111ASP A 131VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.46A | 5kqrA-3lkzA:42.1 | 5kqrA-3lkzA:65.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KQS_A_SAMA307_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.46A | 5kqsA-3lkzA:41.8 | 5kqsA-3lkzA:65.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KQS_A_SAMA307_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.41A | 5kqsA-3lkzA:41.8 | 5kqsA-3lkzA:65.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5KQS_A_SAMA307_0 (GENOME POLYPROTEIN) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.36A | 5kqsA-3lkzA:41.8 | 5kqsA-3lkzA:65.74 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5KR2_A_ROCA101_1 (PROTEASE PR5-SQV) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 5 / 9 | ALA A 290ILE A 231GLY A 246ILE A 247PRO A 295 | NoneNoneNoneNoneSFG A 401 ( 4.4A) | 1.04A | 5kr2A-3tm5A:undetectable | 5kr2A-3tm5A:14.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5LSU_B_SAMB1304_1 (HISTONE-LYSINEN-METHYLTRANSFERASENSD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 3 / 3 | ASN A 205TYR A 252CYH A 274 | SFG A 491 (-3.3A)SFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.28A | 5lsuB-3n71A:5.7 | 5lsuB-3n71A:18.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5B_A_SAMA1001_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105ASP A 131VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.54A | 5m5bA-3lkzA:42.1 | 5m5bA-3lkzA:67.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5B_A_SAMA1001_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105GLU A 111ASP A 131ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A) | 0.56A | 5m5bA-3lkzA:42.1 | 5m5bA-3lkzA:67.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5B_A_SAMA1001_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A) | 0.52A | 5m5bA-3lkzA:42.1 | 5m5bA-3lkzA:67.24 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5M5B_A_SAMA1001_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.44A | 5m5bA-3lkzA:42.1 | 5m5bA-3lkzA:67.24 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5MVS_B_ADNB401_1 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 4 / 8 | GLU A 248LYS A 249ASP A 276ASN A 293 | SFG A 401 (-2.6A)SFG A 401 (-4.9A)SFG A 401 (-3.4A)SFG A 401 (-4.4A) | 0.57A | 5mvsB-3tm5A:12.5 | 5mvsB-3tm5A:20.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5N4T_B_BEZB306_0 (BETA-LACTAMASE VIM-2) |
3axs | PROBABLEN(2),N(2)-DIMETHYLGUANOSINE TRNAMETHYLTRANSFERASETRM1 (Aquifexaeolicus) | 3 / 3 | HIS A 110ASN A 83ALA A 57 | SO4 A 506 (-3.8A)SFG A 501 ( 4.7A)None | 0.78A | 5n4tB-3axsA:2.0 | 5n4tB-3axsA:21.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_A_SAMA301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.38A | 5njvA-3lkzA:41.9 | 5njvA-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_A_SAMA301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.49A | 5njvA-3lkzA:41.9 | 5njvA-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_A_SAMA301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.35A | 5njvA-3lkzA:41.9 | 5njvA-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_B_SAMB301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.43A | 5njvB-3lkzA:42.5 | 5njvB-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_B_SAMB301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.53A | 5njvB-3lkzA:42.5 | 5njvB-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_B_SAMB301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.37A | 5njvB-3lkzA:42.5 | 5njvB-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_B_SAMB301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 86TRP A 87LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-3.4A)SFG A 301 (-3.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 1.43A | 5njvB-3lkzA:42.5 | 5njvB-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_C_SAMC301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.50A | 5njvC-3lkzA:41.1 | 5njvC-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_C_SAMC301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 8 / 12 | GLY A 58TRP A 87LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 1.46A | 5njvC-3lkzA:41.1 | 5njvC-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_C_SAMC301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.38A | 5njvC-3lkzA:41.1 | 5njvC-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_D_SAMD301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83TRP A 87THR A 104HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)SFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.51A | 5njvD-3lkzA:40.8 | 5njvD-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_D_SAMD301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83TRP A 87THR A 104LYS A 105GLU A 111VAL A 132ASP A 146 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A) | 0.96A | 5njvD-3lkzA:40.8 | 5njvD-3lkzA:63.67 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5NJV_D_SAMD301_0 (NS5) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 9 / 12 | GLY A 58GLY A 81GLY A 83TRP A 87THR A 104LYS A 105VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.79A | 5njvD-3lkzA:40.8 | 5njvD-3lkzA:63.67 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_B_SAMB501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 9 | LEU A 92PRO A 94GLY A 118GLY A 122LEU A 143 | SFG A 400 (-4.6A)SFG A 400 (-3.7A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 (-4.2A) | 0.75A | 5o96A-5wyrA:6.95o96B-5wyrA:2.6 | 5o96A-5wyrA:undetectable5o96B-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5O96_H_SAMH501_0 (RIBOSOMAL RNA SMALLSUBUNITMETHYLTRANSFERASE E) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 10 | PRO A 94GLY A 118GLY A 122VAL A 142LEU A 143 | SFG A 400 (-3.7A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 ( 4.1A)SFG A 400 (-4.2A) | 0.63A | 5o96G-5wyrA:6.75o96H-5wyrA:7.0 | 5o96G-5wyrA:undetectable5o96H-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T0K_A_SAMA1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.46A | 5t0kA-3n71A:5.6 | 5t0kA-3n71A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T0K_B_SAMB1304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.46A | 5t0kB-3n71A:5.6 | 5t0kB-3n71A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5T0M_B_SAMB1205_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.53A | 5t0mB-3n71A:5.6 | 5t0mB-3n71A:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_A_SAMA401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 9 | ARG A 19LEU A 203ASN A 205HIS A 206TYR A 252 | SFG A 491 (-3.9A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.52A | 5tegA-3n71A:6.95tegD-3n71A:undetectable | 5tegA-3n71A:15.045tegD-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_A_SAMA401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 9 | LYS A 17ARG A 19ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.60A | 5tegA-3n71A:6.95tegD-3n71A:undetectable | 5tegA-3n71A:15.045tegD-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_A_SAMA401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 9 | LYS A 17LEU A 21ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 1.20A | 5tegA-3n71A:6.95tegD-3n71A:undetectable | 5tegA-3n71A:15.045tegD-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_B_SAMB401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 10 | GLY A 18ARG A 19LEU A 203ASN A 205HIS A 206TYR A 252 | SFG A 491 ( 4.2A)SFG A 491 (-3.9A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.51A | 5tegB-3n71A:7.85tegE-3n71A:undetectable | 5tegB-3n71A:15.045tegE-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_B_SAMB401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 10 | LYS A 17GLY A 18ARG A 19ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)SFG A 491 (-3.9A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 0.55A | 5tegB-3n71A:7.85tegE-3n71A:undetectable | 5tegB-3n71A:15.045tegE-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TEG_B_SAMB401_0 (HISTONE H4 MUTANTPEPTIDE WITHH4K20NORLEUCINEN-LYSINEMETHYLTRANSFERASEKMT5A) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 10 | LYS A 17LEU A 21ASN A 205HIS A 206TYR A 252 | SFG A 491 (-4.7A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) | 1.19A | 5tegB-3n71A:7.85tegE-3n71A:undetectable | 5tegB-3n71A:15.045tegE-3n71A:8.70 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.41A | 5ttfA-3n71A:5.6 | 5ttfA-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.35A | 5ttfB-3n71A:5.7 | 5ttfB-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.32A | 5ttfC-3n71A:5.7 | 5ttfC-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTF_D_SAMD1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.26A | 5ttfD-3n71A:5.7 | 5ttfD-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTG_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.29A | 5ttgA-3n71A:5.7 | 5ttgA-3n71A:17.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TTG_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.30A | 5ttgB-3n71A:5.5 | 5ttgB-3n71A:17.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUY_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.40A | 5tuyA-3n71A:5.9 | 5tuyA-3n71A:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUY_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.48A | 5tuyB-3n71A:5.9 | 5tuyB-3n71A:18.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUZ_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.30A | 5tuzA-3n71A:5.8 | 5tuzA-3n71A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TUZ_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.33A | 5tuzB-3n71A:5.6 | 5tuzB-3n71A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TWJ_A_SAMA201_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE H) |
3bbh | RIBOSOME BIOGENESISPROTEIN NEP1-LIKE (Methanocaldococcusjannaschii) | 5 / 12 | ILE A 161GLY A 162SER A 184LEU A 190VAL A 195 | SFG A 206 ( 4.7A)SFG A 206 (-3.2A)SFG A 206 (-3.3A)SFG A 206 (-4.4A)SFG A 206 (-4.8A) | 0.47A | 5twjA-3bbhA:6.2 | 5twjA-3bbhA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TWJ_A_SAMA201_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE H) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 5 / 12 | LEU A 92GLY A 118GLY A 122SER A 137LEU A 143 | SFG A 400 (-4.6A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 (-3.3A)SFG A 400 (-4.2A) | 0.71A | 5twjA-5wyrA:9.4 | 5twjA-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5TWJ_C_SAMC201_0 (RIBOSOMAL RNA LARGESUBUNITMETHYLTRANSFERASE H) |
3bbh | RIBOSOME BIOGENESISPROTEIN NEP1-LIKE (Methanocaldococcusjannaschii) | 5 / 12 | ILE A 161GLY A 162SER A 184LEU A 190VAL A 195 | SFG A 206 ( 4.7A)SFG A 206 (-3.2A)SFG A 206 (-3.3A)SFG A 206 (-4.4A)SFG A 206 (-4.8A) | 0.48A | 5twjC-3bbhA:6.4 | 5twjC-3bbhA:20.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UPD_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.95A | 5updA-3n71A:5.8 | 5updA-3n71A:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UPD_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.51A | 5updA-3n71A:5.8 | 5updA-3n71A:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5UPD_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | HIS A 206TYR A 252CYH A 274CYH A 276LEU A 266 | NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A)None | 1.30A | 5updA-3n71A:5.8 | 5updA-3n71A:15.56 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V21_A_SAMA1804_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | GLY A 18TYR A 271ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.13A | 5v21A-3n71A:5.7 | 5v21A-3n71A:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V21_A_SAMA1804_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 16TYR A 271HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.50A | 5v21A-3n71A:5.7 | 5v21A-3n71A:20.77 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V21_A_SAMA1804_0 (HISTONE-LYSINEN-METHYLTRANSFERASESETD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 6 / 12 | LYS A 17GLY A 18TYR A 271HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.47A | 5v21A-3n71A:5.7 | 5v21A-3n71A:20.77 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V37_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.18A | 5v37A-3n71A:38.2 | 5v37A-3n71A:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V37_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.51A | 5v37A-3n71A:38.2 | 5v37A-3n71A:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V37_A_SAMA504_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.15A | 5v37A-3n71A:38.2 | 5v37A-3n71A:30.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5V3H_A_SAMA501_0 (N-LYSINEMETHYLTRANSFERASESMYD2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 8 / 10 | LYS A 17ARG A 19HIS A 135ASN A 180ASN A 205HIS A 206TYR A 252PHE A 272 | SFG A 491 (-4.7A)SFG A 491 (-3.9A)SFG A 491 (-3.8A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) | 0.54A | 5v3hA-3n71A:37.9 | 5v3hA-3n71A:30.83 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9I_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.40A | 5v9iA-3n71A:5.5 | 5v9iA-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9I_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.35A | 5v9iB-3n71A:5.6 | 5v9iB-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9I_C_SAMC1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.30A | 5v9iC-3n71A:5.5 | 5v9iC-3n71A:20.46 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9J_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.31A | 5v9jA-3n71A:5.7 | 5v9jA-3n71A:17.58 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5V9J_B_SAMB1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.31A | 5v9jB-3n71A:5.6 | 5v9jB-3n71A:17.58 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_A_SAMA301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87HIS A 110GLU A 111VAL A 132PHE A 133ILE A 147LYS A 182 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-4.1A)SFG A 301 ( 4.1A) | 0.57A | 5vimA-3lkzA:42.2 | 5vimA-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_A_SAMA301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 81GLY A 83GLY A 86LYS A 105VAL A 132PHE A 133ILE A 147 | SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)NoneSFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-4.1A) | 0.93A | 5vimA-3lkzA:42.2 | 5vimA-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_A_SAMA301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 85GLU A 111PHE A 133ILE A 147LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.7A)SFG A 301 (-4.2A)SFG A 301 (-4.1A)SFG A 301 ( 4.1A) | 0.97A | 5vimA-3lkzA:42.2 | 5vimA-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_A_SAMA301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 86TRP A 87HIS A 110GLU A 111VAL A 132PHE A 133ILE A 147 | SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-4.1A) | 1.48A | 5vimA-3lkzA:42.2 | 5vimA-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_A_SAMA301_1 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 4 / 4 | SER A 56THR A 104ASP A 131ASP A 146 | SFG A 301 (-2.6A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-3.8A) | 0.40A | 5vimA-3lkzA:42.2 | 5vimA-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_B_SAMB301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87HIS A 110GLU A 111VAL A 132PHE A 133ILE A 147LYS A 182 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-4.1A)SFG A 301 ( 4.1A) | 0.48A | 5vimB-3lkzA:42.1 | 5vimB-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_B_SAMB301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87LYS A 105HIS A 110GLU A 111VAL A 132PHE A 133ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-4.2A)SFG A 301 (-4.1A) | 0.75A | 5vimB-3lkzA:42.1 | 5vimB-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_B_SAMB301_0 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 7 / 12 | GLY A 81GLY A 85HIS A 110GLU A 111PHE A 133ILE A 147LYS A 182 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.2A)SFG A 301 (-4.1A)SFG A 301 ( 4.1A) | 0.93A | 5vimB-3lkzA:42.1 | 5vimB-3lkzA:69.40 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5VIM_B_SAMB301_1 (METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 4 / 4 | SER A 56THR A 104ASP A 131ASP A 146 | SFG A 301 (-2.6A)SFG A 301 ( 4.7A)SFG A 301 (-3.1A)SFG A 301 (-3.8A) | 0.32A | 5vimB-3lkzA:42.1 | 5vimB-3lkzA:69.40 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSC_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.46A | 5vscA-3n71A:5.7 | 5vscA-3n71A:19.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSC_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.46A | 5vscB-3n71A:5.8 | 5vscB-3n71A:19.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSD_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.30A | 5vsdA-3n71A:5.7 | 5vsdA-3n71A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSD_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.33A | 5vsdB-3n71A:5.7 | 5vsdB-3n71A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSE_A_SAMA1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.46A | 5vseA-3n71A:5.8 | 5vseA-3n71A:19.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSE_B_SAMB1505_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT2) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.47A | 5vseB-3n71A:5.6 | 5vseB-3n71A:19.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSF_A_SAMA3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.31A | 5vsfA-3n71A:5.8 | 5vsfA-3n71A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VSF_B_SAMB3001_0 (HISTONE-LYSINEN-METHYLTRANSFERASEEHMT1) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.32A | 5vsfB-3n71A:5.7 | 5vsfB-3n71A:16.94 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5VUN_A_ACTA804_0 (NITRIC OXIDESYNTHASE, BRAIN) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 4 / 5 | GLY A 493TRP A 524VAL A 521SER A 489 | SFG A 700 (-3.6A)NoneNoneNone | 1.34A | 5vunA-4onqA:undetectable | 5vunA-4onqA:21.60 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WBV_A_SAMA402_0 (HISTONE-LYSINEN-METHYLTRANSFERASEKMT5B) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252PHE A 272CYH A 274CYH A 276 | NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.08A | 5wbvA-3n71A:5.9 | 5wbvA-3n71A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WBV_B_SAMB402_0 (HISTONE-LYSINEN-METHYLTRANSFERASEKMT5B) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252PHE A 272CYH A 274CYH A 276 | NoneSFG A 491 (-4.8A)SFG A 491 (-3.7A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.08A | 5wbvB-3n71A:7.0 | 5wbvB-3n71A:19.20 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_A_SAMA501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | ALA A 269PRO A 270ASP A 291ASP A 318LEU A 367 | SFG A5748 (-4.3A)SFG A5748 (-3.6A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)None | 0.93A | 5wwsA-2yxlA:32.2 | 5wwsA-2yxlA:27.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_A_SAMA501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 8 / 12 | ALA A 269PRO A 270GLY A 272ASP A 291ASP A 318ASP A 337LEU A 367LEU A 371 | SFG A5748 (-4.3A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A)NoneNone | 0.31A | 5wwsA-2yxlA:32.2 | 5wwsA-2yxlA:27.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_A_SAMA501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 5 / 12 | ALA A 93PRO A 94ASP A 142ASP A 89LEU A 193 | SFG A 500 (-3.7A)SFG A 500 (-3.9A)SFG A 500 (-4.0A)SFG A 500 ( 4.4A)None | 1.08A | 5wwsA-3a4tA:29.5 | 5wwsA-3a4tA:24.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_A_SAMA501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 7 / 12 | CYH A 91ALA A 93PRO A 94GLY A 96ASP A 142ASP A 163LEU A 193 | SFG A 500 (-3.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)SFG A 500 (-3.5A)SFG A 500 (-4.0A)SFG A 500 (-3.7A)None | 0.50A | 5wwsA-3a4tA:29.5 | 5wwsA-3a4tA:24.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_B_SAMB501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 7 / 12 | ALA A 269PRO A 270GLY A 272LYS A 273ASP A 291ASP A 318ASP A 337 | SFG A5748 (-4.3A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-2.9A)SFG A5748 (-3.7A)SFG A5748 (-3.6A) | 0.36A | 5wwsB-2yxlA:35.6 | 5wwsB-2yxlA:27.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WWS_B_SAMB501_0 (PUTATIVEMETHYLTRANSFERASENSUN6) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 7 / 12 | CYH A 91ALA A 93PRO A 94GLY A 96LYS A 97ASP A 142ASP A 163 | SFG A 500 (-3.8A)SFG A 500 (-3.7A)SFG A 500 (-3.9A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)SFG A 500 (-4.0A)SFG A 500 (-3.7A) | 0.41A | 5wwsB-3a4tA:29.5 | 5wwsB-3a4tA:24.84 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WY0_A_SAMA800_0 (SMALL RNA2'-O-METHYLTRANSFERASE) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | GLY A 38GLY A 40ASP A 59ASN A 61LEU A 108 | SFG A1198 (-4.3A)SFG A1198 (-3.2A)SFG A1198 (-2.8A)NoneSFG A1198 (-4.8A) | 0.52A | 5wy0A-2xvaA:14.0 | 5wy0A-2xvaA:23.11 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WYQ_A_SAMA401_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 12 / 12 | LEU A 92PRO A 94GLN A 95GLY A 118GLY A 122SER A 137ILE A 138VAL A 142LEU A 143GLY A 145GLY A 146PRO A 149 | SFG A 400 (-4.6A)SFG A 400 (-3.7A)SFG A 400 (-2.7A)SFG A 400 (-3.4A)SFG A 400 (-3.6A)SFG A 400 (-3.3A)SFG A 400 (-4.4A)SFG A 400 ( 4.1A)SFG A 400 (-4.2A)SFG A 400 (-3.2A)SFG A 400 (-3.7A)SFG A 400 (-4.4A) | 0.22A | 5wyqA-5wyrA:32.6 | 5wyqA-5wyrA:undetectable | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5WYQ_B_SAMB301_0 (TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE) |
5wyr | TRNA(GUANINE-N(1)-)-METHYLTRANSFERASE (Pseudomonasaeruginosa) | 12 / 12 | TYR A 91LEU A 92PRO A 94GLN A 95GLY A 118SER A 137ILE A 138TYR A 141LEU A 143GLY A 145GLY A 146PRO A 149 | SFG A 400 (-4.6A)SFG A 400 (-4.6A)SFG A 400 (-3.7A)SFG A 400 (-2.7A)SFG A 400 (-3.4A)SFG A 400 (-3.3A)SFG A 400 (-4.4A)SFG A 400 (-4.6A)SFG A 400 (-4.2A)SFG A 400 (-3.2A)SFG A 400 (-3.7A)SFG A 400 (-4.4A) | 0.24A | 5wyqB-5wyrA:31.4 | 5wyqB-5wyrA:undetectable | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_A_SAMA601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.61A | 5wz1A-3lkzA:41.7 | 5wz1A-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_B_SAMB601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.45A | 5wz1B-3lkzA:41.7 | 5wz1B-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_B_SAMB601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-4.1A) | 0.59A | 5wz1B-3lkzA:41.7 | 5wz1B-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_C_SAMC601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.47A | 5wz1C-3lkzA:41.6 | 5wz1C-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_C_SAMC601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.59A | 5wz1C-3lkzA:41.6 | 5wz1C-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_D_SAMD601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.48A | 5wz1D-3lkzA:41.7 | 5wz1D-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_D_SAMD601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.58A | 5wz1D-3lkzA:41.7 | 5wz1D-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_E_SAME601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.49A | 5wz1E-3lkzA:41.6 | 5wz1E-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_E_SAME601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.60A | 5wz1E-3lkzA:41.6 | 5wz1E-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_F_SAMF601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.48A | 5wz1F-3lkzA:41.7 | 5wz1F-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_F_SAMF601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.58A | 5wz1F-3lkzA:41.7 | 5wz1F-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_G_SAMG601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.45A | 5wz1G-3lkzA:41.6 | 5wz1G-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_G_SAMG601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.59A | 5wz1G-3lkzA:41.6 | 5wz1G-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_H_SAMH601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.48A | 5wz1H-3lkzA:41.6 | 5wz1H-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_H_SAMH601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 86TRP A 87THR A 104LYS A 105HIS A 110GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.60A | 5wz1H-3lkzA:41.6 | 5wz1H-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ1_H_SAMH601_0 (NS5METHYLTRANSFERASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 85TRP A 87GLU A 111ASP A 146ILE A 147 | SFG A 301 (-3.5A)SFG A 301 ( 4.4A)SFG A 301 (-3.7A)SFG A 301 (-3.7A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 1.17A | 5wz1H-3lkzA:41.6 | 5wz1H-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_A_SAMA601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.49A | 5wz2A-3lkzA:41.8 | 5wz2A-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_A_SAMA601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.32A | 5wz2A-3lkzA:41.8 | 5wz2A-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_B_SAMB601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 12 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110ASP A 131VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-3.1A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.43A | 5wz2B-3lkzA:42.0 | 5wz2B-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_B_SAMB601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.33A | 5wz2B-3lkzA:42.0 | 5wz2B-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_C_SAMC601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 11 / 12 | GLY A 58GLY A 81GLY A 83GLY A 86TRP A 87THR A 104LYS A 105HIS A 110VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.4A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.9A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.57A | 5wz2C-3lkzA:41.8 | 5wz2C-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_C_SAMC601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 10 / 12 | GLY A 58GLY A 81GLY A 83TRP A 87THR A 104LYS A 105GLU A 111VAL A 132ASP A 146ILE A 147 | SFG A 301 (-2.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)SFG A 301 (-3.7A)SFG A 301 ( 4.7A)NoneSFG A 301 (-3.7A)SFG A 301 (-4.1A)SFG A 301 (-3.8A)SFG A 301 (-4.1A) | 0.75A | 5wz2C-3lkzA:41.8 | 5wz2C-3lkzA:61.32 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5WZ2_C_SAMC601_0 (NS5 MTASE) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 6 / 12 | GLY A 81GLY A 58GLY A 86GLY A 83THR A 59ASP A 146 | SFG A 301 (-3.5A)SFG A 301 (-2.9A)SFG A 301 (-3.4A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.8A) | 1.34A | 5wz2C-3lkzA:41.8 | 5wz2C-3lkzA:61.32 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5X66_C_MTXC402_1 (THYMIDYLATE SYNTHASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 9 | ILE C 290LEU C 298GLY C 296PHE C 295ASN C 368 | NoneNoneNoneNoneSFG C1002 (-4.1A) | 1.39A | 5x66C-5hr4C:undetectable | 5x66C-5hr4C:14.36 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXD_A_SAMA501_0 (SMYD3METHYLTRANSFERASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.17A | 5xxdA-3n71A:38.1 | 5xxdA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXD_A_SAMA501_0 (SMYD3METHYLTRANSFERASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.49A | 5xxdA-3n71A:38.1 | 5xxdA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXD_A_SAMA501_0 (SMYD3METHYLTRANSFERASE) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.16A | 5xxdA-3n71A:38.1 | 5xxdA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXG_A_SAMA502_0 (SMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.15A | 5xxgA-3n71A:38.2 | 5xxgA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXG_A_SAMA502_0 (SMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.48A | 5xxgA-3n71A:38.2 | 5xxgA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXG_A_SAMA502_0 (SMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.13A | 5xxgA-3n71A:38.2 | 5xxgA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXJ_A_SAMA505_0 (SMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.19A | 5xxjA-3n71A:38.3 | 5xxjA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXJ_A_SAMA505_0 (SMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.43A | 5xxjA-3n71A:38.3 | 5xxjA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5XXJ_A_SAMA505_0 (SMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.10A | 5xxjA-3n71A:38.3 | 5xxjA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_A_SAMA601_0 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | ALA C 363GLY C 365PRO C 418LEU C 462ASN C 481 | SFG C1002 (-3.9A)SFG C1002 (-3.4A)NoneSFG C1002 ( 4.4A)SFG C1002 (-3.8A) | 0.57A | 5ybbA-5hr4C:16.9 | 5ybbA-5hr4C:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_A_SAMA601_1 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 4 / 5 | THR C 316ASP C 361GLU C 413ASN C 460 | SFG C1002 (-4.0A)SFG C1002 ( 4.9A)SFG C1002 (-2.8A)SFG C1002 (-3.2A) | 0.53A | 5ybbA-5hr4C:16.9 | 5ybbA-5hr4C:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_B_SAMB601_0 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | THR C 316ASP C 361CYH C 366LEU C 462ASN C 481 | SFG C1002 (-4.0A)SFG C1002 ( 4.9A)SFG C1002 (-3.2A)SFG C1002 ( 4.4A)SFG C1002 (-3.8A) | 1.04A | 5ybbB-5hr4C:17.1 | 5ybbB-5hr4C:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_B_SAMB601_0 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 6 / 12 | THR C 316ASP C 361PRO C 418LEU C 462ASN C 481PRO C 483 | SFG C1002 (-4.0A)SFG C1002 ( 4.9A)NoneSFG C1002 ( 4.4A)SFG C1002 (-3.8A)SFG C1002 (-4.1A) | 0.62A | 5ybbB-5hr4C:17.1 | 5ybbB-5hr4C:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YBB_B_SAMB601_1 (TYPE IRESTRICTION-MODIFICATION SYSTEMMETHYLTRANSFERASESUBUNIT) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 7 | ALA C 363GLY C 365GLY C 367GLU C 413ASN C 460 | SFG C1002 (-3.9A)SFG C1002 (-3.4A)NoneSFG C1002 (-2.8A)SFG C1002 (-3.2A) | 0.74A | 5ybbB-5hr4C:16.9 | 5ybbB-5hr4C:21.09 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YJO_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252TYR A 270PHE A 272 | NoneNoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 1.20A | 5yjoA-3n71A:38.2 | 5yjoA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YJO_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 7 / 12 | GLY A 18ASN A 180ASN A 205HIS A 206TYR A 252TYR A 270PHE A 272 | SFG A 491 ( 4.2A)SFG A 491 (-4.3A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A)NoneSFG A 491 (-3.7A) | 0.46A | 5yjoA-3n71A:38.2 | 5yjoA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5YJO_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASESMYD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 20ASN A 180HIS A 206TYR A 252TYR A 270 | NoneSFG A 491 (-4.3A)NoneSFG A 491 (-4.8A)None | 1.13A | 5yjoA-3n71A:38.2 | 5yjoA-3n71A:29.53 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5Z6J_A_FOLA201_1 (DIHYDROFOLATEREDUCTASE) |
3tm5 | CRYSTAL STRUCTURE OFTRM14 (Pyrococcusfuriosus) | 3 / 3 | MET A 210ASP A 223ARG A 194 | NoneNoneSFG A 401 ( 4.9A) | 1.17A | 5z6jA-3tm5A:2.7 | 5z6jA-3tm5A:18.13 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZVG_A_SAMA401_0 (389AA LONGHYPOTHETICALNUCLEOLAR PROTEIN) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 8 / 12 | ALA A 267PRO A 270GLY A 272LYS A 273ASP A 318ALA A 319ARG A 320PRO A 339 | SFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.7A)SFG A5748 (-3.4A)SFG A5748 (-4.5A)SFG A5748 (-4.0A) | 0.32A | 5zvgA-2yxlA:38.4 | 5zvgA-2yxlA:32.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZVG_A_SAMA401_0 (389AA LONGHYPOTHETICALNUCLEOLAR PROTEIN) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 7 / 12 | PRO A 94GLY A 96LYS A 97SER A 117ASP A 142ARG A 144PRO A 165 | SFG A 500 (-3.9A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-4.0A)NoneSFG A 500 (-3.9A) | 0.61A | 5zvgA-3a4tA:31.7 | 5zvgA-3a4tA:32.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZVG_B_SAMB401_0 (389AA LONGHYPOTHETICALNUCLEOLAR PROTEIN) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 8 / 12 | ALA A 267PRO A 270GLY A 272LYS A 273ASP A 318ALA A 319ARG A 320PRO A 339 | SFG A5748 (-3.4A)SFG A5748 (-3.6A)SFG A5748 (-3.7A)SFG A5748 (-3.3A)SFG A5748 (-3.7A)SFG A5748 (-3.4A)SFG A5748 (-4.5A)SFG A5748 (-4.0A) | 0.32A | 5zvgB-2yxlA:38.5 | 5zvgB-2yxlA:32.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZVG_B_SAMB401_0 (389AA LONGHYPOTHETICALNUCLEOLAR PROTEIN) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 7 / 12 | PRO A 94GLY A 96LYS A 97SER A 117ASP A 142ARG A 144PRO A 165 | SFG A 500 (-3.9A)SFG A 500 (-3.5A)SFG A 500 (-2.8A)NoneSFG A 500 (-4.0A)NoneSFG A 500 (-3.9A) | 0.65A | 5zvgB-3a4tA:31.7 | 5zvgB-3a4tA:32.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5ZVG_B_SAMB401_1 (389AA LONGHYPOTHETICALNUCLEOLAR PROTEIN) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 3 / 3 | ASP A 291ARG A 296ASP A 337 | SFG A5748 (-2.9A)SFG A5748 (-3.0A)SFG A5748 (-3.6A) | 0.89A | 5zvgB-2yxlA:38.5 | 5zvgB-2yxlA:32.75 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ZW4_A_SAMA302_1 (PUTATIVEO-METHYLTRANSFERASEYRRM) |
3a4t | PUTATIVEMETHYLTRANSFERASEMJ0026 (Methanocaldococcusjannaschii) | 4 / 6 | GLU A 115ARG A 120ASP A 142ASP A 163 | SFG A 500 (-2.6A)SFG A 500 (-4.4A)SFG A 500 (-4.0A)SFG A 500 (-3.7A) | 0.86A | 5zw4A-3a4tA:15.2 | 5zw4A-3a4tA:21.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5K_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 1.10A | 6a5kA-3n71A:5.4 | 6a5kA-3n71A:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5K_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.42A | 6a5kA-3n71A:5.4 | 6a5kA-3n71A:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5M_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.35A | 6a5mA-3n71A:5.4 | 6a5mA-3n71A:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6A5M_A_SAMA805_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFICSUVH6) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | HIS A 206TYR A 252CYH A 274CYH A 276LEU A 266 | NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A)None | 1.16A | 6a5mA-3n71A:5.4 | 6a5mA-3n71A:22.86 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 16ASN A 205HIS A 206TYR A 252CYH A 274 | NoneSFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.26A | 6agoA-3n71A:6.0 | 6agoA-3n71A:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.97A | 6agoA-3n71A:6.0 | 6agoA-3n71A:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.92A | 6agoA-3n71A:6.0 | 6agoA-3n71A:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6AGO_A_SAMA2301_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.31A | 6agoA-3n71A:6.0 | 6agoA-3n71A:18.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_A_SAMA505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.35A | 6bp4A-3n71A:5.4 | 6bp4A-3n71A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_B_SAMB505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.94A | 6bp4B-3n71A:5.5 | 6bp4B-3n71A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_B_SAMB505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.85A | 6bp4B-3n71A:5.5 | 6bp4B-3n71A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BP4_B_SAMB505_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-9 SPECIFIC) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.41A | 6bp4B-3n71A:5.5 | 6bp4B-3n71A:18.61 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6BQ4_A_ADNA401_1 (THERMOSPERMINESYNTHASE ACAULISPROTEIN) |
2yxl | 450AA LONGHYPOTHETICAL FMUPROTEIN (Pyrococcushorikoshii) | 5 / 12 | ASP A 291ASP A 293ASP A 318ALA A 319LEU A 371 | SFG A5748 (-2.9A)NoneSFG A5748 (-3.7A)SFG A5748 (-3.4A)None | 0.83A | 6bq4A-2yxlA:11.3 | 6bq4A-2yxlA:11.47 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6CEN_A_SAMA1301_0 (HISTONE-LYSINEN-METHYLTRANSFERASENSD3) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 11 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.53A | 6cenA-3n71A:5.6 | 6cenA-3n71A:15.35 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6GSD_A_STRA401_0 (PROGESTERONE5-BETA-REDUCTASE) |
3bbh | RIBOSOME BIOGENESISPROTEIN NEP1-LIKE (Methanocaldococcusjannaschii) | 5 / 12 | ILE A 185SER A 61TRP A 193ILE A 198CYH A 196 | SFG A 206 (-4.5A)NoneNoneNoneNone | 1.24A | 6gsdA-3bbhA:undetectable | 6gsdA-3bbhA:17.16 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 16HIS A 206TYR A 252CYH A 274CYH A 276 | NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) ZN A 497 (-2.5A) | 0.92A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | GLY A 18ASN A 205HIS A 206TYR A 252CYH A 274 | SFG A 491 ( 4.2A)SFG A 491 (-3.3A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 0.39A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 16HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)NoneNoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.36A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.00A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6INE_A_SAMA2304_0 (HISTONE-LYSINEN-METHYLTRANSFERASEASH1L) |
3n71 | HISTONE LYSINEMETHYLTRANSFERASESMYD1 (Musmusculus) | 5 / 12 | LYS A 17GLY A 18HIS A 206TYR A 252CYH A 274 | SFG A 491 (-4.7A)SFG A 491 ( 4.2A)NoneSFG A 491 (-4.8A) ZN A 497 (-2.2A) | 1.32A | 6ineA-3n71A:5.8 | 6ineA-3n71A:19.44 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6MHT_D_SAMD328_0 (CYTOSINE-SPECIFICMETHYLTRANSFERASEHHAI) |
4onq | DNAMETHYLTRANSFERASE (Nicotianatabacum) | 6 / 12 | PHE A 488GLY A 490GLY A 493ASP A 539ASN A 460SER A 461 | SFG A 700 (-4.5A)SFG A 700 (-3.5A)SFG A 700 (-3.6A)SFG A 700 ( 4.4A)NoneSFG A 700 (-2.9A) | 0.66A | 6mhtA-4onqA:6.7 | 6mhtA-4onqA:20.21 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6NJ9_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
2xva | TELLURITE RESISTANCEPROTEIN TEHB (Escherichiacoli) | 5 / 12 | ASP A 36GLY A 38GLY A 40LYS A 60ASP A 86 | SFG A1198 ( 4.7A)SFG A1198 (-4.3A)SFG A1198 (-3.2A)SFG A1198 (-3.3A)SFG A1198 (-3.9A) | 0.63A | 6nj9K-2xvaA:11.8 | 6nj9K-2xvaA:20.43 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6NJ9_K_SAMK500_0 (HISTONE-LYSINEN-METHYLTRANSFERASE,H3 LYSINE-79SPECIFIC) |
3lkz | NON-STRUCTURALPROTEIN 5 (WestNilevirus) | 5 / 12 | ASP A 79GLY A 81GLY A 83LYS A 105ASP A 131 | SFG A 301 ( 4.9A)SFG A 301 (-3.5A)SFG A 301 (-3.3A)NoneSFG A 301 (-3.1A) | 0.86A | 6nj9K-3lkzA:7.6 | 6nj9K-3lkzA:20.71 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6QXS_B_FOZB403_0 (THYMIDYLATE SYNTHASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 6 / 12 | LEU C 428ILE C 290LEU C 298GLY C 296PHE C 295ASN C 368 | NoneNoneNoneNoneNoneSFG C1002 (-4.1A) | 1.19A | 6qxsB-5hr4C:undetectable | 6qxsB-5hr4C:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6QXS_D_FOZD403_0 (THYMIDYLATE SYNTHASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 12 | LEU C 428ILE C 290LEU C 298GLY C 296ASN C 368 | NoneNoneNoneNoneSFG C1002 (-4.1A) | 1.00A | 6qxsD-5hr4C:undetectable | 6qxsD-5hr4C:15.85 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6R2E_G_FFOG403_0 (THYMIDYLATE SYNTHASE) |
5hr4 | MMEI (Methylophilusmethylotrophus) | 5 / 11 | ILE C 290LEU C 298GLY C 296PHE C 295ASN C 368 | NoneNoneNoneNoneSFG C1002 (-4.1A) | 1.33A | 6r2eG-5hr4C:undetectable | 6r2eG-5hr4C:15.67 |